Advanced search
Publication Cover
Journal Of Chronic Fatigue Syndrome Volume 10, 2002 - Issue 3-4
Journal homepage
40
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Effects of Benzalkonium Salts on G-protein-Mediated Processes and Surface Membranes

Relevance to Microbial- and Chemical-Induced Diseases

Roberto Patarca-Montero E.M. Papper Laboratory of Clinical Immunology and Molecular Biology,; Microbiology and Immunology, University of Miami School of Medicine, USA
&
Mary Ann Fletcher E.M. Papper Laboratory of Clinical Immunology and Molecular Biology,; Medicine, Microbiology and Immunology, and Psychology, University of Miami, USA
Pages 87-168 | Published online: 04 Dec 2011

References

  • Aubeny, E., J. C. Colau, and A. Nandeuil: Local spermicidal contraception: a compara-tive study of the acceptability and safety of a new pharmaceutical formulation of benzalkonium chloride, the vaginal capsule, with a reference formulation, the pes-sary. Eur. J. ContracepL Rep rod. Health Care, 5 (1): 61–67 (2000).
  • Augustin, C., and O. Damour: Pharmacotoxicological applications of an equivalent dermis: three measurements of cytotoxicity. Cell. Biol. ToxicoL,11 (3–4): 167–171 (1995).
  • Aursnes, J.: Ototoxic effect of iodine disinfectants. Acta Oto-Laryngologica, 93 (3-4): 219–226 (1982a).
  • Aursnes, J.: Ototoxic effect of quaternary ammonium compounds. Acta Oto-Laryngo-logica, 93 (5-6): 421–433 (1982b).
  • Bachert, C.: Die Wirkung von Benzalkoniumchlorid auf das Flimmerepithel der Schleimhaut [Effect of benzalkonium chloride on ciliary epithelium of the mucosa]. HNO, 46 (2): 90–92 (1998).
  • Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall: Activation of dual T cell sig-naling pathways by the chemokine RANTES. Science, 269 (5231): 1727–1730 (1995).
  • Barada, K. A., N. E. Saade, S. F. Atweh, and C. F. Nassar: Neural mediation of vasoactive intestinal polypeptide inhibitory effect on jejunal alanine absorption. Am. J. PhysioL, 275 (4 Pt 1): G822-G828 (1998).
  • Barella, L., M. Loetscher, A. Tobler, M. Baggiolini, and B. Moser: Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation. Biochem. J., 309 (Pt. 3): 773–779 (1995).
  • Bargatze, R. F., and E. C. Butcher: Rapid G-protein-regulated activation event in-volved in lymphocyte binding to high endothelial venules. J. Exp. Med., 178 (1): 367–372 (1993).
  • Barlow, D. W., L. G. Duckert, C. S. Kreig, and G. A. Gates: Ototoxicity of topical otomicrobial agents. Acta OtolaryngoL, 115 (2): 231–235 (1995).
  • Barnes, A. R., and S. Nash: Preservative efficacy in cefuroxime and ceftazidime eye drop formulations. J. Clin. Pharm. Therapeutics, 19 (5): 327–332 (1994).
  • Barnes, A. R.: Compatibility of a commercially available low-density polyethylene eye-drop container with antimicrobial preservatives and potassium ascorbate. J. Clin. Pharm. Ther., 20 (6): 341–344 (1995).
  • Batts, A. H., C. Marriott, G. P. Martin, S. W. Bond, J. L. Greaves, and C. G. Wilson: The use of a radiolabeled saccharin solution to monitor the effect of the preserva-tives thimerosal, benzalkonium chloride and EDTA on human nasal clearance. J. Pharm. Pharmacol., 43 (3): 180–185 (1991).
  • Baudoin, C., C. Garcher, N. Haouat, A. Bron, and P. Gastaud: Expression of inflamma-tory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology, 101 (3): 454–460 (1994).
  • Baudouin, C.: Side effects of antiglaucomatous drugs on the ocular surface. Curr. Opin. OphthalmoL, 7 (2): 80–86 (1996).
  • Baudouin, C.: Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs? InL J. Clin. PharmacoL Res., 16 (1): 29–41 (1996).
  • Baudouin, C., and C. de Lunardo: Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br. J. OphthalmoL, 82 (1): 39–42 (1998).
  • Baudouin, C., P. J. Pisella, K. Fillacier, M. Goldschild, F. Becquet, M. De Saint Jean, and A. B. Bechetoille: Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology, 106 (3): 556–563 (1999).
  • Bayer, S., F. Raul, N. Boehm, A. Klein, and F. Angel: Effets modulateurs des polyamines et du GABA sur la motricite de l'ileon de rat in vitro [Modulatory ef-fects of polyamines and GABA on rat ileal motility in vitro]. GastroenteroL Clin. Biol., 23 (8–9): 824–831 (1999).
  • Beasley, C. R. W., P. Rafferty, and S. T. Holgate: The role of preservatives in Atrovent-induced bronchoconstriction. Thorax, 42: 230–231 (1987).
  • Beasley, R., D. Fishwick, J. F. Miles, and L. Hendeles: Preservatives in nebulizer solu-tions: risks without benefit. Pharmacotherapy, 18(1): 130–139 (1998).
  • Beasley, R., and L. Hendeles: Preservatives in nebulizer solutions: risks without bene-fit—a further comment. Pharmacotherapy, 19 (4): 473–474 (1999).
  • Beckman, E. M., S. A. Force11, C. T. Morita, S. M. Behar, S. T. Furlong, and M. B. Brenner: Recognition of a lipid antigen by CD1-restricted + T cells. Nature, 372: 691–694 (1994).
  • Becquet, F., M. Goldschild, M. S. Moldovan, M. Ettaiche, P. Gastaud, and C. Baudouin: Histopathological effects of topical ophthalmic preservatives on rat corneocon-junctival surface. Curr. Eye Res., 17 (4): 419–425 (1998).
  • Behr, H., M. E. Reverdy, C. Malibat, J. Freney, and J. Fleurette: relationship between the level of minimal inhibitory concentrations of five antiseptics and the presence of qacA gene in Staphylococcus aureus. Pathologie Biologie, 42(5): 438–444 (1994).
  • Bendelac, A., L. Olivier, M. E. Quimby, J. W. Yewdell, R. Bennink, and R. R. Brutkiewicz: CD1 recognition by mouse NK1+ T lymphocytes. Science, 268: 863–865 (1995).
  • Bendix, S.: Benzalkonium chloride. Contact Dermatitis, 35 (4): 264–265 (1996). Berdy, G. J., M. B. Abelson, L. M. Smith, and M. A. George: Preservative-free artifical tear preparations. Assessment of corneal epithelial toxic effects. Arch. OphthalmoL, 110(4): 528–532 (1992).
  • Berg, O. H., K. Lie, and S. K. Steinsvag: The effects of topical nasal steroids on rat re-spiratory mucosa in vivo, with special reference to benzalkonium chloride. Allergy, 52 (6): 627–632 (1997).
  • Berg, O. H., R. N. Henriksen, and S. K. Steinsvag: The effect of a benzalkonium chlo-ride-containing nasal spray on human respiratory mucosa in vitro as a function of concentration and time of action. PharmacoL ToxicoL, 76 (4): 245–249 (1995).
  • Berg, O. H., K. Lie, and S. K. Steinsvag: The effect of decongestive nosedrops on hu-man respiratory mucosa in vitro. Laryngoscope, 104 (9): 1153–1158 (1994).
  • Bergamini, C., G. Negrini, G. F. Finzi, I. Pandiani, and U. Riolo: The use of disinfec-tants in Northern Italy with special attention to the Emilia-Romagna region. Archivio per le Scienze Mediche, 139 (3): 353–356 (1982).
  • Bernal, J. L., M. J. del Nozal, M. T. Martin, J. C. Diez-Masa, and A. Cifuentes: Quantitation of active ingredients and excipients in nasal sprays by high-perfor-mance liquid chromatography, capillary electrophoresis and UV spectroscopy. J. Chromatogr. A., 823 (1–2): 423–431 (1998).
  • Bernstein, I. L.: Is the use of benzalkonium chloride as a preservative for nasal formu-lations a safety concern? A cautionary note based on compromised mucociliary transport. J. Allergy ClM. ImmunoL, 105 (1 Pt 1): 39–44 (2000).
  • Bernstein, J. A., T. Stauder, D. I. Bernstein, and I. L. Bernstein: A combined respira-tory and cutaneous hypersensitivity syndrome induced by work exposure to quater-nary amines. J. Allergy Clin. ImmunoL, 94 (2 Pt 1): 257–259 (1994).
  • Bigliardi, P. L., M. J. Herron, R. D. Nelson, and M. V. Dahl: Effects of detergents on proliferation and metabolism of human keratinocytes. Exp. DermatoL, 3 (2): 89–94 (1994).
  • Birkenbach, M., K. Josefsen, R. Yalamanchili, G. Lenoir, and E. Kieff: Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide recep-tors. J. ViroL, 67 (4): 2209–2220 (1993).
  • Bischoff, S. C., M. Krieger, T. Brunner, A. Rot, V. von Tschamer, M. Baggiolini, and C. A. Dahinden: RANTES and related chemokines activate human basophil granu-locytes through different G protein-coupled receptors. Eur. J. ImmunoL, 23 (3): 761–767 (1993).
  • Bjerknes, R. and S. K. Steinsvag: Inhibition of human neutrophil actin polymerization, phagocytosis and oxidative burst by components of decongestive nosedrops. PharmacoL ToxicoL, 73 (1): 41–45 (1993).
  • Bleau, G. and M. Desaulniers: High-performance liquid chromatographic assay of benzatkonium in plasma. J. Chromatogr., 487 (1): 221–227 (1989).
  • Boek, W. M., S. G. Romeijn, K. Graamans, J. C. Verhoef, F. W. Merkus, and E. H. Huizing: Validation of animal experiments on ciliary function in vitro. II. The influ-ence of absorption enhancers, preservatives and physiologic saline. Acta OtolaryngoL, 119 (1): 98–101 (1999).
  • Bolognesi, D. P.: Immunobiology of the human immunodeficiency virus envelope and its relationship to vaccine strategies. MoL Biol. Med., 7: 1–15 (1990).
  • Bonnema, J. D., K. A. Rivlin, A. T. Ting, R. A. Schoon, R. T. Abraham, and P. J. Leibson: Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exo-cytosis. J. ImmunoL, 152 (5): 2098–2104 (1994).
  • Boucher, M., M. T. Roy, and J. Henderson: Possible association of benzalkonium chlo-ride in nebulizer solutions with respiratory arrest. AnnaL of Pharmacotherapy, 26 (6): 772–774 (1992).
  • Bourlioux, P., M. C. Barc, and A. German: Evaluation of bactericidal activity of anti-septics on the cutaneous flora of holoxenic hairless mouse. AnnaL MicrobioL, 134A (1): 115–124 (1983).
  • Boume, M. S., M. L. H. Flindt, and J. M. Walker: Asthma due to industrial use of chloramine. Br. Med. J., 2: 10–12 (1979).
  • Braat, J. P., G. Ainge, J. A. Bowles, D. H. Richards, D. Van Riessen, W. J. Visser, and E. Rijntjes: The lack of effect of benzalkonium chloride on the cilia of the nasal mu-cosa in patients with perennial allergic rhinitis: a combined functional, light, scan-ning and transmission electron microscopy study. Clin. Exp. Allergy, 25 (10): 957–965 (1995).
  • Bracken, W. M., F. Cuppage, R. L. McLaury, C. Furwin, and C. D. Klaassen: Compar-ative effectiveness of topical treatments for hydrofluoric acid bums. J. OccupaL Med., 27 (10): 733–739 (1985).
  • Braga, P. C., G. Piatti, M. Dal Sasso, and A. Bemini: The effects of calcitonin nasal preparations and their excipients on mucociliary clearance in an ex vivo frog palate test. J. Pharm. PharmacoL, 44(11): 938–940 (1992).
  • Brom, J. and W. Konig: Cytokine-induced (interleukin-3, - 6, and -8 and tumor necro-sis factor-beta) activation and deactivation of human neutrophils. Immunology, 75 (2): 281–285 (1992).
  • Bron, A. J., P. Daubas, R. Siou-Mermet, and C. Trinquand: Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears. Eye, 12 (Pt 5): 839–847 (1998).
  • Brooks, R. W., K. L. George, B. C. Parker, J. O. Falkinham, M., and H. Gruff: Recov-ery and survival of nontuberculous mycobacteria under various growth and decon-tamination conditions. Can. J. MicrobioL, 30 (9): 1112–1117 (1984).
  • Brosin, A., V. Wolf, A. Mattheus, and H. Heise: Use of XTT-assay to assess the cytotoxicity of different surfactants and metal salts in human keratinocytes (HaCaT). A feasible method for in vitro testing of skin irritants. Acta Derm. VenereoL, 77 (1): 26–28 (1997).
  • Bubis, M. and N. Zisapel: Facilitation and inhibition of G- protein regulated protein se-cretion by melatonin. Neurochem. Int., 27 (2): 177–183 (1995).
  • Bueb, J. L., A. Da Silva, M. Mousli, and Y. Landry: Natural polyamines stimulate G-proteins. Biochem. J., 282 (Pt 2): 545–550 (1992).
  • Burd, T., B. P. Conroy, S. C. Meyer, and W. C. Allen: The effects of chlorhexidine irri-gation solution on contaminated bone-tendon allografts. Am. J. Sports Med., 28 (2): 241–244 (2000).
  • Burge, P. S.: Occupational risks of gluteraldehyde. Br. Med. J., 299: 342 (1989). Burstein, N. L.: Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Investigative OphthalmoL Vi- sual Sci., 19(3): 308–313 (1980).
  • Burstein, N. L.: Preservative alteration of corneal permeability in humans and rabbits. Investigative OphtahlmoL Visual Sci., 25 (12): 1453–1457 (1984).
  • Burstein, N. L.: The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. Transactions of the Ophthalmological Societies of the United Kingdom, 104 (Pt 4): 402–409 (1985).
  • Burstein, S., J. Budrow, M. Debatis, S. A. Hunter, and A. Subramanian: Phospholipase participation in cannabinoid-induced release of free arachidonic acid. Biochemical PharmacoL, 48 (6): 1253–1264 (1994).
  • Buttar, H. S.: Embryotoxicity of benzalkonium chloride in vaginally treated rats. J. AppL ToxicoL, 5 (6): 398–401 (1985).
  • Byrne, C., and T. M. Healy: Efficacy of a new quarternary ammonium compound against TB. Ir. J. Med. Sci., 168 (1): 45–46 (1999).
  • Cáceres-Rfos, H., J. Rodriguez-Tafur, F. Bravo-Puccio, C. Maguiria-Vargas, D. Carrillo-Ramos, and R. Patarca: Verruga peruana: an infectious endemic angiomatosis. CriL Rev. Oncog., 6 (1): 47–56 (1995).
  • Campagna, P., A. Macri, M. Rolando, and G. Calabria: Chronic topical eye preserva-tive-free beta-blocker therapy effect on the ocular surface in glaucomatous patients. Acta OphthalmoL Scand. SuppL, (224): 53 (1997).
  • Campanella, L., L. Aiello, C. Colapicchioni, and M. Tomassetti: Lidocaine and benzalkonium analysis and titration in drugs using new ISFET devices. J. Pharm. Biomed. Anal., 18 (1–2): 117–125 (1998).
  • Camussi, G., G. Montrucchio, E. Lupia, A. De Martino, L. Perona, M. Arese, A. Vercellone, A. Toniolo, and F. Bussolino: Platelet-activating factor directly stimu-lates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J. ImmunoL, 154: 6492–6501 (1995).
  • Chahdi, A., L. Daeffler, J. L. Bueb, J. P. Gies, and Y. Landry: The M2 muscarinic re-ceptor antagonist methoctramine activates mast cells via pertussis toxin-sensitive G proteins. Naunyn Schmiedebergs Arch. PharmacoL, 357 (4): 357–362 (1998).
  • Chahdi, A., L. Daeffler, J. P. Gies, and Y. Landry: Drugs interacting with G protein al-pha subunits: selectivity and perspectives. Fundam. Clin. PharmacoL, 12 (2): 121–132 (1998).
  • Chang, S. W., R. F. Chi, C. C. Wu, and M. J. Su: Benzalkonium chloride and gentamicin cause a leak in corneal epithelial cell membrane. Exp. Eye Res., 71(1): 3–10 (2000).
  • Chantler, E., H. Fisher, S. Solanki, and M. Elstein: Quantification of the in vitro activ-ity of some compounds with spermicidal activity. Contraception, 46 (6): 527–536 (1992).
  • Charlton, J. F., I. R. Schwab, and R. Stuchell: Topical urea as a treatment for non-infec-tious keratopathy. Acta OphthalmoL Scand., 74 (4): 391–394 (1996).
  • Chiambaretta, F., P. Pouliquen, and D. Rigal: Allergie et conservateurs. A propos de trois cas d'allergie au chlorure de benzalkonium [Allergy and preservatives. Apro-pos of 3 cases of allergy to benzalkonium chloride]. J. Fr. OphtalmoL, 20 (1): 8–16 (1997).
  • Cho, J. H., Y. S. Kwun, H. S. Jang, J. M. Kang, Y. S. Won, and H. R. Yoon: Long-term use of preservatives on rat nasal respiratory mucosa: effects of benzalkonium chlo-ride and potassium sorbate. Laryngoscope, 110 (2 Pt 1): 312–317 (2000).
  • Chou, A., S. Hori, and M. Takase: Ocular toxicity of beta-blockers and benzalkonium chloride in pigmented rabbits: electrophysiological and morphological studies. Jpn. J. OphthalmoL, 29 (1): 13–23 (1985).
  • Chyla, A., and E. Zelazowska: Using of thin-layer chromatography for identification and quantitative determination of benzalkonium chloride in eye drops. Acta Pol. Pharm., 56 (6): 419–423 (1999).
  • Cifuentes, A., J. L. Bernal, and J. C. Diez-Masa: Use of detergents and high contents of organic solvents for simultaneous quantitation of ionic and nonionic drugs by electrokinetic chromatography. J. Chromatogr. A., 824 (1): 99–108 (1998).
  • Clague, J. R., J. A. Post, and O. A. Langer: Cationic amphiphiles prevent calcium leak induced by ATP depletion in myocardial cells. Circulation Res., 72 (1): 214–218 (1993).
  • Clark, R. J.: Exacerbation of asthma after nebulized beclomethasone diproprionate. Lancet, 1: 574 (1986).
  • Clutterbuck, E. J. and C. J. Sanderson: Human eosinophil hematopoiesis studied in vi-tro by means of murine eosinophil differentiation factor (IL-5): production of func-tionally active eosinophils from normal human bone marrow. Blood, 71: 646–651 (1988).
  • Cockerell, C. J., M. A. Whitlow, O. F. Webster, and A. E. Friedman-Kien: Epithelioid angiomatosis: a distinct vascular disorder in patients with AIDS or AIDS-related complex. Lancet, 2: 654–656 (1987).
  • Cockerell, C. J. and P. E. LeBoit: Bacillary angiomatosis: a newly characterized, pseudoneoplastic, infectious, cutaneous vascular disorder. J. Am. Acad. Dermatol., 22: 501–512 (1990).
  • Cockerell, C., P. Tiemo, A. Friedman-Kien, and K. S. Kim: Clinical, histologic, microbiologic, and biochemical characterization of causative agent of bacillary (epithelioid) angiomatosis: a rickettsia' illness with features of bartonellosis. J. In-vest. Dermatol., 97: 812–817 (1991).
  • Coeffier, E., D. Joseph, and B. B. Vargaftig: Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists. J. Immunol., 147: 2595–2602 (1991).
  • Coggins, C.: Avoiding HIV transmission: women need more options. Sex Transm. In-fect., 75 (6): 374–375 (1999).
  • Coleman, J. W., S. T. Holgate, M. K. Church, and R. C. Godfrey: Immunoglobulin E decapeptide-induced 5- hydroxytryptaniine release from rat peritoneal mast cells. Comparison with corticotropin-(1–24)-peptide, polyarginine, polylysine and anti-gen. Biochem. J., 198 (3): 615–619 (1981).
  • Coleman, J. W.: Neuraminidase- and benzalkonium chloride-dependent inhibition of basic peptide-induced rat mast cell secretion. Immunol. Lett., 5 (4): 197–201 (1982).
  • Collin, H. B. and B. E. Grabsch: The effect of ophthalmic preservatives on the heating rate of the rabbit corneal epithelium after keratectomy. Am. J. Optometry Physiolog. Optics, 59 (3): 215–222 (1982).
  • Collin, H. B. and N. Carroll: Ultrastructural changes to the corneal endothelium due to benzalkonium chloride. Acta Ophthalmologica, 64 (2): 226–231(1986).
  • Collins, P. D., S. Marleau, D. A. Griffiths-Johnson, P. J. Jose, and T. J. Williams: Co-operation between interleukin-5 and the chemokine eotaxin to induce eosi-nophil accumulation in vivo. J. Exp. Med., 182: 1169–1174 (1995).
  • Conroy, B. P., J. O. Anglen, W. A. Simpson, G. Christensen, G. Phaup, R. Yeager, and B. J. Gainor: Comparison of castile soap, benzalkonium chloride, and bacitracin as irrigation solutions for complex contaminated orthopaedic wounds. J. Orthop. Trauma, 13 (5): 332–337 (1999).
  • Constant, P., F. Davodeau, M.-A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J.-J. Fournid: Stimulation of human T cells by nonpeptidic mycobacterial ligands. Sci-ence, 264: 267–270 (1995).
  • Corazza, M. and A. Virgili: Airborne allergic contact dermatitis from benzalkonium chloride. Contact Dermatitis, 28 (3): 195–196 (1993).
  • Corsini, E., A. Primavera, M. Marinovich, and C. L. Galli: Selective induction of cell-associated interleukin- lalpha in murine keratinocytes by chemical allergens. Toxicology, 129 (2–3): 193–200 (1998).
  • Couillin, I., B. Culmann-Pencioleiii, E. Gomard, J. Choppin, J. P. Levy, J. G. Guillet, and S. Saragosti: Impaired cytotoxic T lymphocyte recognition due to genetic varia-tions in the main immunogenic region of the human immunodeficiency virus I nef protein. J. Exp. Med., 180: 1129–1134 (1994).
  • Courtot, A. M., G. Nikas, A. Gravanis, and A. Psychoyos: Effects of cholic acid and `Protectaid' formulations on human sperm motility and ultrastructure. Hum. Re-product., 9 (11): 1999–2005 (1994).
  • Cox, N. H.: Allergy to benzalkonium chloride simulating dermatomyositis. Contact Dermatitis, 31(1): 50 (1994).
  • Cozens, R. M. and M. R. Brown: Effect of nutrient depletion on the sensitivity of Pseu-domonas cepacia to antimicrobial agents. J. PharmaceuL Sci., 72 (11): 1363–1365 (1983).
  • Cracco, C. and G. Filogamo: Mesenteric neurons in the adult rat are responsive to ileal treatment with benzalkonium chloride. Intern. J. Develop. Neurosci.,11 (1): 49–61 (1993).
  • Cracco, C., and G. Filogamo: Neuronal and non-neuronal plasticity in the rat following myenteric denervation. Adv. Exp. Med. Biol., 429: 159–169 (1997).
  • Cunliffe, I. A., C. A. McIntyre, R. C. Rees, and I. G. Rennie: The effect of topical cholinergic medications on human Tenon's capsule fibroblasts in tissue culture. Graefes Archive for Clin. Exp. OphthalmoL, 233 (8): 507–512 (1995a).
  • Cunliffe, I. A., C. A. McIntyre, R. C. Rees, and I. G. Rennie: Pilot study on the effect of topical adrenergic medications on human Tenon's capsule fibroblasts in tissue cul-ture. Br. J. OphthalmoL, 79 (1): 70–75 (1995b).
  • Cusano, F. and S. Luciano: Contact allergy to benzalkonium chloride and gluter-aldehyde in a dental nurse. Contact Dermatitis, 28 (2): 127 (1993).
  • Cybuiski, Z. R.: Determination of benzalkonium chloride by gas chromatography. J. PharmaceuL Sci., 73 (12): 1700–1702 (1984).
  • Daeffler, L. K. Nadra, V. Eichwald, S. Ohresser, and Y. Landry: Effect of NMDA re-ceptor ligands on mast cell histamine release, a reappraisal. Naunyn Schmiedebergs Arch. PharmacoL, 359 (6): 512–518 (1999).
  • Dai, L. C., K. West, R. Littaua, K. Takahashi, and F. A. Ennis: Mutation of human im-munodeficiency virus type I at aniino acid 585 on gp4i results in loss of killing by CD8+ A24- restricted cytotoxic T lymphocytes. J. ViroL, 66: 3151–3154 (1992).
  • Damour, O., S. Z. Hua, F. Lasne, M. Villain, P. Rousselle, and C. Collembel: Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes. Burns, 18 (6): 479–485 (1992).
  • Dantas, P. E., E. Uesugui, M. C. Nishiwaki-Dantas, and L. J. Mimica: Antibacterial ac-tivity of anesthetic solutions and preservatives: an in vitro comparative study. Cor-nea, 19 (3): 353–354 (2000).
  • Daoud, N. N., P. A. Crooks, R. Speak, and P. Gilbert: Determination of benzalkonium chloride by chemical ionization mass spectroscopy. J. PharmaceuL Sci., 72 (3): 290–292 (1983).
  • Darbord, J. C., F. Vincent, L. Boutron, V. Goury, and S. Guyomard: Susceptibility of Torulopsis glabrata in the presence of six antifungal agents determined by compar-ison of growth at several pHs. AppL Environ. MicrobioL, 53 (3): 593–595 (1987).
  • De Jong, C., T. Stolwijk, E. Kuppens, R. de Keizer, and J. van Best: Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluor-escence of the cornea in glaucoma. Graefes Arch. for Clin. Exp. Ophthalmol., 232 (4): 221–224 (1994).
  • De Saint Jean, M., F. Brignole, A. F. Bringuier, A. Bauchet, G. Feldmann, and C. Baudouin: Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest. Ophthalmol. Vis. Sci., 40 (3): 619–630 (1999).
  • De Saint Jean, M., C. Debbasch, F. Brignole, P. Rat, J. M. Warnet, and C. Baudouin: Toxicite des collyres beta-bloquants avec ou sans conservateur dans un modele in vitro de cellules conjonctivales humaines. J. Fr. Ophtalmol., 23 (2): 111–121 (2000a).
  • De Saint Jean, M., C. Debbasch, F. Brignole, P. Rat, J. M. Warnet, and C. Baudouin: Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr. Eye Res., 20 (2): 85–94 (2000b).
  • Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton, and J. Mills: Genomic structure of an attenuated quasi species of HIV-I from a blood transfusion donor and recipients. Science, 270: 988–991 (1995).
  • Dealler, S.: Cat scratch disease, bartonellosis, and Kaposi sarcoma. Lancet, 2 (8625): 1422–1423 (1988).
  • Debbasch, C., M. de Saint Jean, P. J. Pisella, P. Rat, J. M. Warnet, and C. Baudouin: Cytotoxicite des ammoniums quaternaires sur une lignee de cellules conjonctivales humaines. [Quaternary ammonium cytotoxicity in a human conjunctival cell line]. J. Fr. Ophtalmol., 22 (9): 950–958 (1999).
  • Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. D. Marzio, S. Marynon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littynan, and N. R. Landau: Identification of a major co-receptor for primary iso-lates of HIV-1. Nature, 381 (6584): 661–666 (1996).
  • Denis, P., P. Demailly, and H. Saraux: Clinical evaluation of betaxolol in ophthalmic suspension with or without preservative agent in patients with glaucoma or occular hypertension. J. Francais d'Ophthalmologie, 16 (5): 297–303 (1993).
  • Diaz-Ramon, L., A. Aguirre, J. A. Raton-Nieto, and M. de Miguel: Contact dermatitis from benzoxonium chloride. Contact Dermatitis 41(1): 53–54 (1999).
  • Diker, K. S., H. Yardimei, and M. Arda: Effects of disinfectants on Campylobacter jejuni. Mikrobiyoloji Bulteni, 21(2): 86–90 (1987).
  • Dobner, T., I. Wolf, T. Enuich, and M. Lipp: Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma. Eur. J. Immunol., 22 (11): 2795–2799 (1992).
  • Dondi dall' Orologio, G., R. Lorenzi, M. Anselmi, and V. Opisso: Dentin desensitizing effects of Gluma Alternate, Health-Dent; Desensitizer and Scotchbond Multi-Pur-pose. Am. J. Dent., 12 (3): 103–106 (1999).
  • Dougherty, M. J. and R. D. Ward: Methods of reducing Ascogregatina chagasi parasitaemia in laboratory colonies of Lutzomyoa longipalpis. Parasitologia, 33 (Suppl.): 185–191 (1991).
  • Doughty, M. J.: Acute effects of chlorobutanol- or benzalkonium chloride-containing artificial tears on the surface features of rabbit corneal epithelial cells. Optometry Vision Sci., 71(9): 562–572 (1994).
  • Doughty, M. J.: Changes in lactate dehydrogenase activity in bovine corneal stroma and epithelium in response to in vitro toxic challenges in the enucleated eye test. Optom. Vis. Sci., 74 (4): 198–206 (1997).
  • Doughty, M. J.: Assessment of the effects of cetylpyridium chloride on water content of the collagen-keratocyte matrix of the mammalian corneal stroma ex vivo. Biochim. Biophys. Acta, 1426 (3): 449–458 (1999).
  • Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton: HIV- I entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature, 381 (6584): 667–673 (1996).
  • Drulak, M., A. M. Wallbank, I. Lebag, L. Werboshi, and L. Poffenroth: The relative ef-fectiveness of commonly used disinfectants in inactivation of Coxsackie B5. J. Hyg. Cam., 81: 77–87 (1978).
  • Dubois, P. M., F. Andris, R. A. Shapiro, L. K. Gilliland, M. Kaufman, J. Urbain, J. A. Ledbetter, and O. Leo: T cell long-term hyporesponsiveness follows antigen recep-tor engagement and results from defective signal transduction. Eur. J. Immuna, 24 (2): 348–354 (1994).
  • Dunn, B. J., M. A. MacKinnon, N. F. Knowlden, D. J. Billmaier, M. J. Derelanko, G. M. Rusch, D. J. Naas, and R. R. Dahlgren: Topical treatments for hydrofluoric acid dermal burns. Further assessment of efficacy using an experimental pig model. J. Occup. Environ. Med., 38 (5): 507–514 (1996).
  • Durand-Cavagna, G., P. Delort, P. Duprat, Y. Bailly, B. Plazonnet, and L. R. Gordon: Corneal toxicity studies in rabbits and dogs with hydroxyethyl cellulose and benzalkonium chloride. Fundamental Appl. Toxica, 13 (3): 500–508 (1989).
  • DVV: Kommentar zur Richtlinie des Bundesundheitsamtes und der Deutschen Vereingung zur Bekampfung der Viruskrankheiten zur Prufung von chemischen Disinfektionsmitteln auf Wirksamkeit gegen Viren. Hygiene Medizin, 9: 177–179 (1984).
  • Dyer, D. L., K. B. Gerenraich, and P. S. Wadhams: Testing a new alcohol-free hand sanitizer to combat infection. AORN J., 68 (2): 239–241, 243–244, 247–251 (1998).
  • Edgar, R., and E. Bibi: MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J. Bacteria, 179 (7): 2274–2280 (1997).
  • Eich, J., H. Durholt, T. Steger-Hartmann, and E. Wagner: Specific detection of mem-brane-toxic substances with a conductivity assay. Ecotoxica Environ. Saf, 45 (3): 228–235 (2000).
  • El-Ghazzawy, A. G., N. Gupta, T. J. Swope, A. D. Kulkarni, W. M. Panneton, S. M. Robinson, M. L. Niehoff, D. L. Kaminski, and C. H. Andrus: Evaluation of benzalkonium chloride chemoneurolytic proximal gastric vagotomy. Surg. Endosc., 12(3): 207–211 (1998).
  • Elrod, L., Jr., T. G. Golich, and J. A. Morley: Determination of benzalkonium chloride in eye acre products by high-performance liquid chromatography and solid-phase extraction or on-line column switching. J. Chromatogr., 625 (2): 362–367 (1992).
  • Emadi-Khiav, B., M. Mousli, C. Bronner, and Y. Landry: Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli. Eur. J. PharmacoL, 272 (1): 97–102 (1995).
  • Emtestam, L., and M. Nyren: Electrical impedance for quantification and classification of experimental skin reactions. Am. J. Contact DermaL, 8 (4): 202–206 (1997).
  • Engel, L. S., M. C. Callegan, J. M. Hill, A. T. Folkens, Y. Shimomura, and R. J. O'Callaghan: The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn. J. OphthalmoL, 40 (2): 212–219 (1996).
  • Enjalbert, L., Y. Levade, and P. Marchetti: Comparison of 2 antiseptic soaps used for preoperative showers. Pathologie Biologie, 32 (5 Pt 2): 604–606 (1984).
  • Erny, R. and C. Siboni: Benzalkonium chloride tampons. Local tolerance and effects on cervix mucus. J. de Gynecologie, Obstetrique et Biologie de la ReproducL, 12 (7): 767–774 (1983).
  • Erny, R. and C. Sibomi: The effect of benzalkonium chloride on ovulatory cervical mucus. Acta Eurapaea Fertilitatis, 18(2): 109–111 (1987).
  • Estevez, M. D., M. R. Vieytes, and L. M. Botana: Study of the activation mechanism of adriamycin on rat mast cells. Agents Actions, 42 (3–4): 86–91 (1994).
  • Estevez, M. D., M. R. Vieytes, and L. M. Botana: Mitoxantrone induces nonimmuno-logical histamine release from rat mast cells. Inflamm. Res., 45 (3): 113–117 (1996).
  • Estevez, M. D., M. R. Vieytes, M. C. Louzao, A. Alfonso, N. Vilarino, and L. M. Botana: The antineoplastic drug vinorelbine activates non-immunological hista-mine release from rat mast cells. Inflamm. Res., 46 (4): 119–124 (1997).
  • Estil, S., E. Haaskjold, R. Bjerknes, and S. B. Refsum: Early cell kinetic effects of some drugs on the rat corneal and conjunctival epithelia. Acta OphthalmoL Scand., 73 (6): 496–500 (1995).
  • Euerby, M. R.: High-performance liquid chromatography of benzalkonium chlorides—variation in commercial preparations. J. Clin. Hospital Pharm., 10 (1): 73–77 (1985).
  • Eun, H. C., J. H. Chung, S. Y. Jung, K. H. Cho, and K. H. Kim: A comparative study of the cytotoxicity of skin irritants on cultured human oral and skin keratinocytes. Br. J. Derrmatol., 130 (1): 24–28 (1994).
  • Fabreguette, A., S. Zhi Hua, F. Lasne, and O. Damour: Evaluation of the cytotoxicity of antiseptics used in current practice on cultures of fibroblasts and keratinocytes. Pathologie Biologie, 42 (9): 888–892 (1994).
  • Fajardo, L. F., H. H. Kwan, J. Kowalski, S. D. Prionas, and A. C. Wilson: Dual role of tumor necrosis factors in angiogenesis. Am. J. PathoL, 140: 539–544 (1992).
  • Fan, T. Y. and G. M. Wall: Determination of benzalkonium chloride in ophthalmic so-lutions containing tyloxapol by solid-phase extraction and reversed-phase high-per-formance liquid chromatography. J. PharmaceuL Sci., 82(11): 1172–1174(1993).
  • Fan, Y. and M. A. McCloskey: Dual pathways for OTP-dependent regulation of chernoattractant-activated K+ conductance in murine J774 monocytes. J. Biol. Chem., 269 (50): 31533–31543 (1994).
  • Fang, J. Y., L. R. Hsu, Y. B. Huang, and Y. H. Tsai: Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. InL J. Pharm., 180 (2): 137–149 (1999).
  • Fazeli, F., B. J. Dezube, J. Allen-Ryan, A. B. Pardee, and R. M. Ruprecht: Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type Tin human peripheral blood mononuclear cells and in cultured T cells. Blood, 77 (8): 1653–1656 (1991).
  • Febronio, L. H., S. Britto-Garcia, J. S. de Oliveira, and S. Zucoloto: Megaesophagus in rats. Res. Exp. Med. (Berl.), 197 (2): 109–115 (1997).
  • Federspil, P.: Topically induced ototoxicity. HNO, 32 (2): 81–83 (1984).
  • Feld, K. M., W. I. Higuchi, and C. C. Su: Influence of benzalkonium chloride on the dissolution rate behavior of several solid-phase preparations of cholesterol in bile acid solutions. J. PharmaceuL Sci., 71(2): 182–188 (1982).
  • Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger: HVV-1 entry cofactor: func-tional CDNA cloning of a seven-transmembrane, G protein-coupled receptor. Sci-ence, 272: 872–877 (1996).
  • Ferguson, J., J. H. Gibbs, and J. S. Beek: Lymphocyte subsets and Langerhans cells in allergic and irritant patch test reactions: histometric studies. Contact Dermatitis, 13 (3): 166–174 (1985).
  • Fesenko, V. P., I. S. Krivoshein, A. A. Mogiliastyi, and N. V. Pavlova: Ispol' zovanie miramistina dlia lecheniia eksperimental'noi gnoinoi rany v usloviiakh narushen-nogo perifericheskogo krovoobrashcheniia [Use of miramistin in the treatment of experimental suppurative wounds in states of impaired peripheral blood circula-tion]. Klin. Khir., 8: 30–32 (1996).
  • Finzi, G. F., U. Riolo, G. Negrini, C. Bergamini, and I. Pandiani: Analysis of the use of disinfectants in Italy particularly in Southern Italy. Archivio per le Scienze Mediche, 139 (3): 357–360 (1982).
  • Fischer, T., C. Bronner, Y. Landry, and M. Mousli: The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway. Biochim. et Biophys. Acta, 1176 (3): 305–312 (1993).
  • Fisher, A. A.: Allergic contact dermatitis and conjunctivitis from benzalkonium chlo-ride. Cutis, 39 (5): 381–383 (1987).
  • Fisher, L. B. and H. I. Maibach: Effect of some irritants on human epidermal mitosis. Contact Dermatitis, 1(5): 273–276 (1975).
  • Fletcher, M. A., G. C. Baron, M. R. Ashman, M. A. Fischl, and N. G. Klimas: The use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn. Clin. ImmunoL, 5: 69–81 (1987).
  • Fletcher, M. A., S. Azen, B. Adelberg, G. Gjerset, J. Hassett, J. Kaplan, J. Niland, T. Odom-Mayor, J. Parker, D. Stites, J. Mosely, and the Transfusion Safety Study Group: Immunophenotyping in a mutlicenter study: the transfusion safety experi-ence. Clin. Immuno1 ImmunopathoL, 52: 38–47 (1989).
  • Flood, S.: Hydrofluoric acid bums. Am. Family Phys., 37 (3): 175–182 (1988).
  • Follea, G., P. Saint-Laurent, F. Bigey, S. Gayet, M. Bientz, and J. P. Cazenave: Evalua-tion bacteriologique quantitative d'une methode de desinfection cutanee chez les donneurs de sang [Quantitative bacteriological evaluation of a method for skin dis-infection in blood donors]. Transfus. Clin. Biol., 4 (6): 523–531 (1997).
  • Forster, R., T. Enuich, E. Kremmer, and M. Lipp: Expression of the G-protein-coupled receptor BLRI defines mature, recirculating B cells and a subset of T-helper mem-ory cells. Blood, 84 (3): 830–840 (1994).
  • Fox, D. A., M. L. Epstein, and P. Bass: Surfactants selectively ablate enteric neurons of the rat jejunum. J. Pharmaco1 Exp. Therapeutics, 227 (2): 538–544 (1983).
  • Fox, D. A. and P. Bass: Selective myenteric neuronal denervation of the rat jejunum. Differential control of the propagation of migrating myoelectric complex and basic electric rhythm. Gastroenterology, 87 (3): 572–577 (1984).
  • Fox, J. G., C. M. Beaucage, C. A. Folta, and G. W. Thornton: Nosocomial transmission of Serratia marcescens in a veterinary hospital due to contamination by benzal-konium chloride. J. Clin. MicrobioL, 14 (2): 157–160 (1981).
  • Fraki, J. E., K. Kalimo, P. Tuohimaa, and E. Aantaa: Contact allergy to various compo-nents of topical preparations for treatment of external otitis. Acta Oto-Laryngo-logica, 100 (5–6): 414–418 (1985).
  • Frateschi, M., G. F. Zandonini, and G. C. Mazzoleni: Benzalkonium in local contra-ception and sexually-transmitted diseases. Annali di Ostetricia, Ginecologia, Medicina Perinatale, 111 (4): 265–269 (1990).
  • Fuchs, T., A. Meinert, W. Aberer, F. A. Bahmer, K. P. Peters, G. G. Lischka, A. Schulze-Dirks, F. Enders, and P. J. Frosch: Benzalkonium chloride—a relevant con-tact allergen or irritant? Results of a multicenter study of the German Contact Al-lergy Group. Hautarzt, 44 (11): 699–702 (1993).
  • Fuhrman, L. C. Jr., and R. T. Stroman: Stability of vancomycin in an extemporane-ously compounded ophthalmic solution. Am. J. Health SysL Pharm., 55 (13): 1386–1388 (1998).
  • Fujii, M., S. Yasuhara, Y. Ohmoto, S. Sugiyama, Y. Nagatsugu, S. Katoh, T. Yamashita, H. Ito, S. Oie, and A. Kamiya: [Prevention of MRSA spread in the neurosurgical field] No Shinkei Geka, 24 (3): 241–245 (1996).
  • Furrer, P., J. M. Mayer, B. Plazonnet, and R. Gurny: Ocular tolerance of preservatives on the murine cornea. Eur. J. Pharm. Biopharm., 47 (2): 105–112 (1999).
  • Furuta, T., K. Sakata, T. Kunieda, and Y. Kishimoto: On the pathogenesis of intestinal aganglionosis. A consideration based on electron microscopic observations of ex-perimental and clinical aganglionoses. Experientia, 36 (9): 1073–1074 (1980).
  • Furuta, T. and K. Yjhara: Relationship between the effects on bacterial activity of se-lected disinfectants and the hydrophobic characters of dibasic acid diesters. Chem. Pharmaceut. Bull., 40 (5): 1309–1312 (1992).
  • Gainor, B. J., D. E. Hockman, J. O. Anglen, G. Christensen, and W. A. Simpson: Benzalkonium chloride: a potential disinfecting irrigation solution. J. Orthop. Trauma, 11(2): 121–125 (1997).
  • Gallo, C. J., A. R. Hand, T. L. Jones, and L. A. Jaffe: Stimulation of Xenopus oocyte maturation by inhibition of the G-protein alpha S subunit, a component of the plasma membrane and yolk platelet membranes. J. Cell Biol., 130 (2): 275–284 (1995).
  • Ganaway, J. R.: Effect of heat and selected chemical disinfectants upon infectivity of spores of Bacillus piliformis (Tyzzer' s disease). Lab. Animal Sci., 30 (2 Pt 1): 192–196 (1980).
  • Gao, J. L. and P. M. Murphy: Human cytomegalovirus open reading frame US28 en-codes a functional beta chernokine receptor. J. Biol. Chem., 269 (46): 28539–28542 (1994).
  • Garcia, S. B., M. C. Kawasaky, J. C. Silva, A. C. Garcia-Rodrigues, T. J. Borelli-Bovo, A. C. Iglesias, and S. Zucoloto: Intrinsic myenteric denervation: a new model to in-crease the intestinal absorptive surface in short-bowel syndrome. J. Surg. Res., 85 (2): 200–203 (1999).
  • Garcia, S. B., J. S. Oliveira, L. Z. Pinto, G. Muccillo, and S. Zucoloto: The relationship between megacolon and carcinoma of the colon: an experimental approach. Car-cinogenesis, 17 (8): 1777–1779 (1996).
  • Garcia, S. B., L. Z. Pinto, S. Zucoloto, and J. S. Oliveira: Experimental megaileum. Res. Exp. Med. (Berl), 195 (4): 249–253 (1995).
  • Gaton, D. D., H. Stiebel-Kalish, N. Loya, D. Weinberger, Y. Kashtan, and A. Solo-mon: The effect of tear substitute and silicone oil on re-epithelisation of the cornea. Eye, 12 (Pt 1): 141–144 (1998).
  • Gaumnitz, E. A., P. Bass, M. A. Osinski, M. A. Sweet, and C. Singaram: Electro-physiological and pharmacological responses of chronically denervated lower esophageal sphincter of the opossum. Gastroenterology, 109 (3): 789–799 (1995).
  • Gaustad, J. W., C. R. McDuff, and H. J. Hatcher: Test method for the evaluation of virucidal efficacy of three common liquid surface disinfectants on a simulation en-vironmental surface. AppL Micro., 28: 748–752 (1974).
  • Gaylord, M. S., P. A. Pittman, J. Bartness, A. A. Tuinman, and V. Lorch: Release of benzalkoniumm chloride from a heparin-banded umbilical catheter with resultant factitious hypenatremia and hyperkalemia. Pediatrics, 87 (5): 631–635 (1991).
  • Gerard, C. and N. P. Gerard: The proinflammatory seven-transmembrane segment re-ceptors of the leukocyte. Gum. Opin. ImmunoL, 6 (1): 140–145 (1994).
  • Gerberick, G. F., L. W. Cruse, C. M. Miller, and G. M. Ridder: Selective modulation of B-cell activation markers CD86 and I-Ak on murine draining lymph node cells fol-lowing allergen or irritant treatment. ToxicoL AppL PharmacoL, 159 (2): 142–151 (1999).
  • Gerberick, G. F., L. W. Cruse, C. M. Miller, E. E. Sikorski, and G. M. Ridder: Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment. ToxicoL AppL PharmacoL, 146 (1): 1–10 (1997).
  • Ghandy, P. A., A. D. Sawant, L. A. Wilson, and D. G. Ahearn: Adaptation and growth of Serratia marcescens in contact lens disinfectant solutions containing chlor-hexidine gluconate. AppL Environ. MicrobioL, 59 (1): 183–188 (1993).
  • Girardo, P., M. E. Reverdy, A. Martra, and J. Fleurette: Determination of bactericidal minimum concentrations of 3 antiseptics and I disinfectant on 580 hospital Gram-negative bacilli. Pathologie Biologie, 37 (5 Pt 2): 605-611(1989).
  • Gismondo, M. R., L. Drago, A. Lombardi, M. C. Fassina, and B. Mombelli: Anti-microbial and sporicidal efficacy of various disinfectant solutions. Minerva Medica, 86 (1–2): 21–32 (1995).
  • Gismondo, M. R., L. Drago, A. Lombardi, M. C. Fassina, and B. Mombelli: Efficacia antimicrobica e sporicida di vane soluzioni disinfettanti [Antimicrobial and sporicidal efficacy of various disinfectant solutions]. Minerva Medica, 86(1–2): 21–32 (1995).
  • Gobbels, M. and M. Spitznas: Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Ophthalmology, 99 (6): 873–878 (1992).
  • Goh, C. L.: Contact sensitivity to topical antimicrobials. II. Sensitizing potentials of some topical antimicrobials. Contact Dermatitis, 21(3): 166–171(1989).
  • Goldman, L.: Bartonellosis and Kaposi sarcoma of AIDS. Lancet, 1 (8462): 852 (1989).
  • Gomez-Gomar, A., M. M. Gonzalez-Aubert, J. Garces-Torrents, and J. Costa-Segarra: Determination of benzalkonium chloride in aqueous ophthalmic preparations by high-performance liquid chromatography. J. Pharmaceut. Biomed. Anal., 8 (8–12): 871–876 (1990).
  • Gonzalo Garijo, M. A., J. A. Duran Quintana, P. Bobadilla Gonzalez, and P. Maiquez Asuero: Anaphylactic shock following povidone. Ann. Pharmacother., 30 (1): 37–40 (1996).
  • Gordon, V., S. Parry, K. Bellamy, and R. Osbome: Assessment of chemical disinfec-tants against human immunodeficiency virus: overcoming the problem of cylotoxicity and the evaluation of selective actives. J. Virological Methods, 45 (3): 247–257 (1993).
  • Goskonda, V. R., R. A. Hill, M. A. Khan, I. K. Reddy, A. D. Russell, J. R. Furr, and D. Lloyd: Permeability of chemical delivery systems across rabbit corneal (SIRC) cell line and isolated corneas: a comparative study. Emergence of resistance to biocides during differentiation of acanthamoeba castellanii. Pharm. Dev. Technol., 5 (3): 409–416 (2000); J. Antimicrob. Chemother., 46 (1): 27–34 (2000).
  • Goto, S. and J. L. Grosfeld: The effect of a neurotoxin (benzalkonium chloride) on the lower esophagus. J. Surg. Res., 47 (2): 117–119 (1989).
  • Gott, V. L., and R. L. Daggett: Serendipity and the development of heparin and carbon surfaces. Ann. Thorac. Surg., 68 (3 Suppl): S19-S22 (1999).
  • Graf, P.: Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Rhinology, 34 (1): 9–13 (1996). Graf, P.: Rhinitis medicamentosa: aspects of pathophysiology and treatment. Allergy, 52 (40 Suppl): 28–34 (1997).
  • Graf, P.: Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhini-tis and rhinitis medicamentosa. Clin. Ther., 21(10): 1749–1755 (1999).
  • Graf, P., H. Hallen, and J. E. Juto: Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clin. Exp. Allergy, 25 (5): 395–400 (1995).
  • Graf, P., and H. Hallen: Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope, 106 (5 Pt 1): 605–609 (1996).
  • Graf, P., and H. Hallen: Nasdroppar varje dag kan ge kronisk nastappa [Daily adminis-tration of nose drops can cause chronic nasal congestion]. Lakartidningen, 93 (4): 259–262 (1996).
  • Graf, P., and H. Hallen: One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment. ORL J. Otorhinolaryngol. Relat. Spec., 59 (1): 39–44 (1997).
  • Graf, P., J. Enerdal, and H. Hallen: Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. Arch. Otolaryngol. Head Neck Surg., 125 (10): 1128–1132 (1999).
  • Grant, R. L., and D. Acosta: Prolonged adverse effects of benzalkonium chloride and sodium dodecyl sulfate in a primary culture system of rabbit corneal epithelial cells. Fundam. AppL ToxicoL, 33 (1): 71–82 (1996).
  • Greco, R. S. and R. A. Harvey: The role of antibiotic bonding in the prevention of vas-cular prosthetic infections. Annals Surg., 195 (2): 168–171 (1982).
  • Greco, R. S., R. A. Harvey, P. C. Smilow, and J. V. Tesoriero: Prevention of vascular prosthetic infection by a benzalkonium-oxacillin bonded polytetrafluoroethylene graft. Surg. GynecoL ObsteL, 155 (1): 28–32 (1982).
  • Greco, R. S., S. Z. Trooskin, A. P. Donetz, and R. A. Harvey: The application of antibi-otic bonding to the treatment of established vascular prosthetic infection. Arch. Surg., 120 (1): 71–75 (1985).
  • Grobler, S. R., N. J. Basson, and R. J. Rossouw: Shear bond strength, microleakage and antimicrobial properties of Aelitebond. Am. J. Dent., 9 (3): 120–124 (1996).
  • Grundemar, L., J. L. Krstenansky, and R. Hakanson: Neuropeptide Y and truncated neuropetide Y analogs evoke histamine release from rat peritoneat mast cells. A di-rect effect on G proteins? Eur. J. PharmacoL, 258 (1–2): 163–166 (1994).
  • Guerin-Mechin, L., F. Dubois-Brissonnet, B. Heyd B, and J. Y. Leveau: Specific varia-tions of fatty acid composition of Pseudomonas aeruginosa ATCC 15442 induced by quaternary ammonium compounds and relation with resistance to bactericidal activity. J. AppL MicrobioL, 87 (5): 735–742 (1999).
  • Guin, J. D., and P. Wilson: Onycholysis from nail lacquer: a complication of nail en-hancement? Am. J. Contact DermaL, 10(1): 34–36 (1999).
  • Gupta, M., and D. K. Majumdar: Effect of concentration, pH, and preservative on in vi-tro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aque-ous drops. Indian J. Exp. Biol., 35 (8): 844–849 (1997).
  • Gutierrez, C. B., J. I. Rodriguez Barbosa, J. Suarez, O. R. Gonzalez, R. I. Tascon, and E. F. Rodriguez Ferri: Efficacy of a variety of disinfectants against Actinobacillus pleuropneumoniae serotype 1. Am. J. Vet. Res., 56 (8): 1025–1029 (1995).
  • Haas, A., B. Conradt, and W. Wickner: G-protein ligands inhibit in vitro reactions of vacuole inheritance. J. Cell BioL, 126 (1): 87–97 (1994).
  • Hadzijahic, N., M. E. Reneharn, C. K. Ma, X. Zhang, and R. Fogel: Myenteric plexus destruction alters morphology of rat intestine. Gastroenterology, 105 (4): 1017–1028 (1993).
  • Hagiwara, S., M. Kuchira, N. Ogura, N. Ogawara, T. Seki, and I. Ishikawa: Effect of subgingival plaque control by direct irrigation technique. H. Clinical and microbio-logical changes after irrigation with acrinol or benzalkonium chloride solution. Kokubyo Gakkai Zasshi—J. Stomatological Soc., Japan, 56 (3): 435–443 (1989).
  • Hakansson, B., A. Forsgren, H. Tegner, and N. G. Toremalm: Inhibitory effects of na-sal drops components on granulocyte chemotaxis. PharmacoL ToxicoL, 64 (4): 321–323 (1989).
  • Hall, A. J. and G. E. Duke: Effect of selective gastric intrinsic denervation on gastric motility in turkeys. Poult. Sci., 79 (2): 240–244 (2000).
  • Hallen, H. and P. Graf: Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. Clin. Exp. Al-lergy, 25 (5): 401–405 (1995).
  • Halvax, J. J., G. Wiese, J. A. Arp, J. M. Vermeer, W. P. van Bennekom, and A. BuIt: Rapid determination of benzalkonium chloride in pharmaceutical preparations with flow injection liquid-liquid extraction. J. PharmaceuL Biomed. Anal., 8 (3): 243–252 (1990).
  • Hamill, R. J., E. D. Houston, P. R. Georghiou, C. E. Wright, M. A. Koza, R. M. Cadle, P. A. Goepfert, D. A. Lewis, G. J. Zenon, and J. E. Clarridge: An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann. Intern. Med., 122 (10): 762–766 (1995).
  • Haruta, Y., Y. Ohashi, and S. Matsuda: Corneal epithelial deficiency induced by the use of beta-blocker eye drops. Eur. J. OphthalmoL, 7 (4): 334–339 (1997).
  • Harvey, R. A. and R. S. Greco: The noncovalent bonding of antibiotics to a poly-tetrafluoroethylene-benzalkonium graft. Annals Surg., 194 (5): 642–647 (1981).
  • Harvey, R. A., D. V. Alcid, and R. S. Greco: Antibiotic bonding to polytetra-fluoroethylene with tridodecyl-methylammonium chloride. Surgery, 92: 504–512 (1982).
  • Hasmann, F. A., A. Jr. Pessoa, and I. C. Roberto: Beta-xylosidase recovery by reversed micelles. Use of cationic surfactant. AppL Biochem. BiotechnoL, 84–86: 1101–1111 (2000).
  • Hegna, I. K. and O. G. Clausen: An investigation of the bactericidal and fungicidal ef-fects of certain disinfectants by use of a capacity test. Annales de l'Institut Pas-teur-Microbiology, 139 (4): 473–483 (1988).
  • Heinig, K. and C. Vogt: Determination of surfactants by capillary electrophoresis. Electrophoresis, 20 (15-16): 3311–3328 (1999).
  • Heir, E., G. Sundheim, and A. L. Holck: Identification and characterization of quater-nary ammonium compound resistant staphylococci from the food industry. Int. J. Food MicrobioL, 48 (3): 211–219 (1999).
  • Heir, E., G. Sundheim, and A. L. Holck: The qacG gene on plasmid pST94 confers re-sistance to quaternary ammonium compounds in staphylococci isolated from the food industry. J. AppL MicrobioL, 86 (3): 378–388 (1999).
  • Heir, E., G. Sundheim, and A. L. Holck: The Staphylococcus qacH gene product: a new member of the SMR family encoding multidrug resistance. FEMS MicrobioL Lett., 163 (1): 49–56 (1998).
  • Heir, E., G. Sundheim, and A. L. Holck: Resistance to quaternary ammonium com-pounds in Staphylococcus spp. isolated from the food industry and nucleotide se-quence of the resistance plasmid pST827. J. AppL BacterioL, 79 (2): 149–156 (1995).
  • Hendrick, D. J. and D. J. Lane: Formalin asthma in hospital staff. Br. Med. J., 1: 607–608 (1975).
  • Hernandes, L., S. Zucoloto, and E. P. Alvares: Effect of myenteric denervation on in-testinal epithelium proliferation and migration of suckling and weanling rats. Cell. Prolif., 33 (3): 127–138 (2000).
  • Hernandez Bermejo, J. P.: Respuesta clinica de distintos segmentos del colon a la denervacion quimica. Estudio experimental en ratas [Clinical response of different colonic segments to chemical denervation: an experimental study] Cir. Pediatr., 8 (3): 113–117 (1995).
  • Herold B.C., Kirkpatrick R., Marcellino D., Travelstead A., Pilipenko V., Krasa H., Bremer J., Dong L.J., Cooper M.D. Bile salts: natural detergents for the prevention of sexually transmitted diseases. Antimicrob. Agents Chemother., 43 (4): 745–751 (1999).
  • Herouet, C., M. Cottin, P. Galanaud, J. Leclaire, and F. Rousset: Contact sensitizers de-crease 33D1 expression on mature Langerhans cells. Eur. J. DermatoL, 9 (3): 185–190 (1999).
  • Higham, A., P. Noble, D. G. Thompson, and G. J. Dockray: Increased sensitivity of gastrin cells to gastric distension following antral denervation in the rat. J. PhysioL (Lond.), 503 (Pt 1): 169–175 (1997a).
  • Higham, A., C. Vaillant, B. Yegen, D. G. Thompson, and G. J. Dockray: Relation be-tween cholecystokinin and antral innervation in the control of gastric emptying in the rat. Gut, 41(1): 24–32 (1997b).
  • Hiramatsu, K., H. Yoshida, T. Kimura, and K. Takagi: Midkine induces histamine re-lease from mast cells and the immediate cutaneous response. Biochem. MoL Biol. InL, 44 (3): 453–462 (1998).
  • Hitomi, S., S. Baba, H. Yano. Y. Morisawa, and S. Kimura: Antimicrobial effects of electrolytic products of sodium chloride—comparative evaluation with sodium hypo-chlorite solution and efficacy in handwashing. Kansenshogaku Zasshi, 72 (11): 1176–1181 (1998).
  • Hitosugi, M., K. Maruyama, and A. Takatsu: A case of fatal benzalkonium chloride poisoning. InL J. Legal Med., 111 (5): 265–266 (1998).
  • Hodges, N. A., S. P. Denyer, G. W. Hanlon, and J. P. Reynolds: Preservative efficacy tests in formulated nasal products: reproducibility and factors affecting preserva-tive activity. J. Pharm. PharmacoL, 48 (12): 1237–1242 (1996).
  • Hofmann, T., G. Wolf, and B. Koidl: Die Wirkung topischer Kortikosteroide und topischer Antihistaminika auf das Flimmerepithel humaner Nasenschleimhaut in vitro [Effect of topical corticosteroids and topical antihistaminics on ciliary epithe-lium of human nasal mucosa in vitro]. HNO, 46(2): 146–151 (1998).
  • Holle, G. E.: Changes in the structure and regeneration mode of the rat small intestinal mucosa following benzalkonium chloride treatment. Gastroenterology, 103 (3): 1122 (1992).
  • Holle, G. E.: Changes in muscularis externa of rat small intestine after myenteric abla-tion with benzalkonium chloride: electron microscopic and morphometric study. Dig. Dis. Sci., 43 (12): 2666–2675 (1998).
  • Holliday, M. R., E. Corsini, S. Smith, D. A. Basketter, R. J. Dearman, and I. Kimber: Differential induction of cutaneous TNF-alpha and IL-6 by topically applied chem-icals. Am. J. Contact DermaL, 8 (3): 158–164 (1997).
  • Holliday, M. R., R. J. Dearman, E. Corsini, D. A. Basketter, and I. Kimber: Selective stimulation of cutaneous interleukin 6 expression by skin allergens. J. AppL ToxicoL, 16 (1): 65–70 (1996).
  • Horuk, R.: The interleukin-8-receptor family: from chemokines to malaria. ImmunoL Today, 15 (4): 169–174 (1994).
  • Hosoya, K. and V. H. Lee: Cidofovir transport in the pigmented rabbit conjunctiva. Curr. Eye Res., 16 (7): 693–697 (1997).
  • Hsieh, P. C., S. A. Siegel, B. Rogers, D. Davis, and K. Lewis: Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc. NatL Acad. Sci. USA, 95 (12): 6602–6606 (1998).
  • Hunter, P. R.: Discrimination of strains of Candida albi cans isolated from deep and su-perficial sites by resistotyping. Mycoses, 38 (1-2): 37–40 (1995).
  • Ichijima, H., W. M. Petroll, J. V. Vester, and H. D. Cavanagh: Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea, 11 (3): 22 1-225 (1992).
  • Ikarashi, Y., Y. Tsukamoto, T. Tsuchiya, and A. Nakamura: Influence of irritants on lymph node cell proliferation and the detection of contact sensitivity to metal salts in the murine local lymph node assay. Contact Dermatitis, 29(3): 128–132(1993).
  • Imayasu, M., T. Moriyama, J. Ohashi, H. Ichijima, and H. D. Cavanagh: A quantitative method for LDH, MDH and albumin levels in tears with ocular surface toxicity scored by Draize criteria in rabbit eyes. CLAO J., 18 (4): 260–266 (1992).
  • Imayasu, M., T. Moriyama, H. Ichijima, J. Ohashi, W. M. Petroll, J. V. Jester, and H. D. Cavanagh: The effects of daily wear of rigid gas permeable contact lenses treated with contact lens care solutions containing preservatives on the rabbit cornea. CLAO J., 20 (3): 183–188 (1994).
  • Innocenti, A.: Occupational asthma due to benzalkonium chloride. Med. Lavoro, 69: 713–715 (1978).
  • Inoue, T., T. Okasora, and E. Okamoto: Effect on muscarinic acetylcholine receptors after experimental neuronal ablation in rat colon. Am. J. PhysioL, 269 (6 Pt 1): G940-G944 (1995).
  • Iwata, F., E. M. Kuehl, G. F. Reed, L. M. McCain, W. A. Gahl, and M. I. Kai-ser-Kupfer: A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis. MoL Genet. Metab., 64 (4): 237–242 (1998).
  • JaM, P. T., M. J. Fitzpatrick, P. C. Phelps, I. K. Berezesky, and B. F. Trump: Studies of skin toxicity in vitro: dose-response studies on JB6 cells. ToxicoL PathoL, 20 (3 Pt 1): 394–404 (1992).
  • Jannasch, R.: Capillary isotachophoresis—a new method in drug analysis. H. Analytical capillary isotachophoresis of the synthetic peptide substance P. Pharmazie, 40 (6): 398–403 (1985).
  • Jelinek, A., and H. P. Klocking: In vitro toxicity of surfactants in U937 cells: cell mem-brane integrity and mitochondrial function. Exp. ToxicoL PathoL, 50(4–6): 472–476 (1998).
  • Jimidar, M., I. Beyns, R. Rome, R. Peeters, and G. Musch: Determination of benzal-konium chloride in drug formulations by capillary electrophoresis (CE). Biomed. Chromatogr., 12 (3): 128–130 (1998).
  • Jodal, M., S. Holmgrem, O. Lundgren, and A. Sjoqvist: Involvement of the myenteric plexus in the cholera toxin-induced net fluid secretion in the rat small intestine. Gastroenterology, 105 (5): 1286–1293 (1993).
  • Johnson, R. P., A. Trocha, D. M. Buchanan, and B. D. Walker: Identification of over-lapping HLA class I-restricted cytotoxic T-cell epitopes in a conserved region of the human immunodeficiency virus type I envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med., 175: 961–971 (1992).
  • Johnston, M. D., E. A. Simons, and R. J. Lambert: One explanation for the variability of the bacterial suspension test. J. AppL MicrobioL, 88 (2): 237–242 (2000).
  • Jono, K., T. Uemura, M. Kuno, and E. Higashide: Bactericidal activity and killing rate of benzalkonium chloride and chlorhexidine gluconate. Yakugasu Zasshi—J. Pharm-aceuL Soc. Japan, 105 (g): 751–759 (1985).
  • Jono, K., T. Takaywna, M. Kuno, and E. Higashide: Effect of alkyl chain length of benzalkonium chloride on the bactericidal activity and binding to organic materials. Chem. PharmaceuL Bull., 34 (10): 4215–4224 (1986).
  • Kai, H., M. Saito, K. Furusawa, Y. Oda, Y. Okano, K. Takahama, and T. Miyata: Pro-tective effect of surface-active phospholipids against the acid-inducing inhibition of the tracheal mucociliary transport. Jap. J. PharmacoL, 49 (3): 375–380 (1989).
  • Kajino, T.: Effect of benzalkonium chloride on cultured V79 cells. Shigaku-Odon-tology, 75 (1): 63–74 (1987).
  • Kaminski, N. E., W. S. Koh, K. H. Yang, M. Lee, and F. Kessler: Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. PharmacoL, 48 (10): 1899–1908 (1994).
  • Kanerva, L., R. Jolanki, and T. Estlander: Occupational allergic contact dermatitis from benzalkonium chloride. Contact Dermatitis, 42 (6): 357–358 (2000).
  • Kapoor, H., S. Murlidhar, M. Jais, R. Thakur, and P. Aggarwal: Evaluation of efficacy of Dettol-H in hospital use. J. Commun. Dis., 30(3): 167–170 (1998).
  • Kaulfers, P. M.: Epidemiologie and Ursachen mikrobieller Biozidresistenzen [Epide-miology and reasons for microbial resistance to biocides] ZentralbL Hyg. Umweltmed., 197 (1–3): 252–259 (1995).
  • Kawa, J. E., E. J. Higginbotham, I. L. Chang, and B. Y. Yue: Effects of antiglaucoma medications on bovine trabecular meshwork cells in vitro. Exp. Eye Res., 57 (5): 557–565 (1993).
  • Kawakami, S., R. H. Callicott, and N. Zhang: Trace analysis of benzalkonium chloride on skin by flow injection ionspray mass spectrometry-mass spectrometry. Analyst, 123 (3): 489–491 (1998).
  • Kawana, R., T. Kitamura, O. Nakagomi, I. Matsumoto, M. Arita, N. Yoshihara, K. Yanagi, A. Yamada, O. Morita, Y. Yoshida, Y. Furuya, and S. Chiba: Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Derma-tology, 195 Suppl 2: 29–35 (1997).
  • Keeven, J., S. Wrobel, M. Portoles, and B. T. DeCicco: Evaluating the preservative ef-fectiveness of RGP lens care solutions. CLAO J., 21(4): 238–241 (1995).
  • Keller, N., D. Moore, D. Carper, and A. Longwell: Increased corneal permeability in-duced by the dual effects of transient tear fihn acidification and exposure to benzalkonium chloride. Exp. Eye Res., 30 (2): 203–210 (1980).
  • Kemeny, L., T. Ruzicka, A. Dobozy, and G. Michel: Role of interleukin-8 receptor in skin. InL Arch. Allergy ImmunoL, 104(4): 317–322 (1994).
  • Khurana, M. L., and K. N. Pandey: Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins. Arch. Biochem. Biophys., 316(1): 392–398 (1995).
  • Kiec-Swierczynska, M.: Srodki odkazajace w zakladach sluzby zdrowia rodzaj i czestosc stosowania [Disinfectants in health service institutions and frequency of their use]. Med. Pr., 46 (1): 39–46 (1995).
  • Kiec-Swierczynska, M.: Wstepna ocena wplywu srodkow odkazajacych na powsta-wanie zmian skornych u pracownikow sluzby zdrowia [Preliminary assessment of the effect of disinfectants on skin changes in health service workers] Med. Pr., 46 (2): 149–154 (1995).
  • Kiec-Swierczynska, M., B. Krecisz, and U. Ruta: Udzial alergii natychmiastowej w powstawaniu uczulenia kontaktowego na srodki odkazajace [Immediate hypersen-sitivity in the development of contact sensitivity to disinfectant agents] Med. Pr., 47 (6): 533–539 (1996).
  • Kiec-Swierczynska, M., and B. Krecisz: Przyczyny uczulenia zawodowego u pomocy dentystycznych, na podstawie materialu Instytutu Medycyny Pracy w Lodzi. Med. Pr., 51(2): 145–149 (2000).
  • Kimura, T., J. Nakamura, and H. Sezaki: Effect of synthetic surfactants on drug ab-sorption in the presence of a physiologic surfactant, sodium taurocholate, in rats. J. Pharmacobio-Dynamics, 8 (8): 661–668 (1985).
  • Kinane, T. B., J. D. Finder, A. Kawashima, D. Brown, M. Abbate, W. J. Fredericks, V. P. Sukhatme, F. J. Rauscher, III, and L. Ercolani: LLC-PK I cell growth is repressed by WTI inhibition of G-protein alpha i-2 protooncogene transcription. J. Biol. Chem., 270 (51): 30760–30764 (1995).
  • King, R. O., G. D. Bell, A. H. Short, B. V. Heathcole, and C. J. Hawkey: In vitro en-hancement of cholesterol dissolution by commonly used drugs. J. Pharm. Pharmacol., 37 (9): 610–613 (1985).
  • Kligman, L. H., A. N. Sapadin, and E. Schwartz: Peeling agents and irritants, unlike tretinoin, do not stimulate collagen synthesis in the photoaged hairless mouse. Arch. Dermatol. Res., 288 (10): 615–620 (1996).
  • Kneer, I., H. Hoh, and K.W. Ruprecht: 1991 new developments regarding the conjunc-tiva. Klinische Montsblatter fur Augenheilkunde, 203 (6): 380–383 (1993).
  • Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPrieto, V. M. Elner, S. G. Elner, and R. M. Striter: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science, 258: 1798–1801 (1992).
  • Koch, T. R. and J. D. Cook: Benzalkonium interference with test methods for potas-sium and sodium. Clin. Chem., 36 (5): 807–808 (1990).
  • Koenig, S., A. J. Conkey, Y. A. Brewah, G. M. Jones, S. Leath, L. J. Boots, V. Davey, G. PanWeo, J. F. Demarest, C. Carter, C. Wannebo, J. R. Yannelli, S. A. Rosenberg, and H. C. Lane: Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progres-sion. Nature Med., 1: 330–336 (1995).
  • Kolde, G. and J. Knop: Different cellular reaction patterns of epidermal Langerhans cells after application of contact sensitizing, toxic, and tolerogenic compounds. A comparative ultrastructural and morphometric time-course analysis. J. Invest. Dermatol., 89 (1): 19–23 (1987).
  • Kolly, M., A. Pecoud, and P. C. Frei: Additives contained in drug formulations most frequently prescribed in Switzerland. Annal. Allergy, 62 (1): 21–25 (1989).
  • Koniushkevich, V. A., E. M. Rakhman'ko, S. M. Leshchev, and T. V. Titenkova: Effektivnyi rastvoritel' biologicheskikh tkanei [An effective biological tissue sol-vent]. Klin. Lab. Diagn., 2: 49–50 (1995).
  • Kossendrup, D., M. Wiederholt, and F. Hoffmann: Influence of cyclosporin A, dexa-methasone, and benzalkonium chloride (BAK) on corneal epithelial wound healing in the rabbit and guinea pig eye. Cornea, 4 (3): 177–181 (1985–1986).
  • Kovacs-Hadady, K., and I. Fabian: The determination of benzalkonium chloride in eye-drops by difference spectrophotometry. J. Pharm. Biomed. Anal., 16 (5): 733–740 (1998).
  • Kovelesky, R. A., P. R. Byron, and J. Venitz: Peptidoleukotriene (PLT) release and ab-sorption from the airways of the isolated perfused guinea pig lung following chemi-cal and antigenic challenge. Pharm. Res., 16 (2): 321–326 (1999).
  • Krogsrud, N. E., and A. I. Larsen: Airborne irritant contact dermatitis from benzal-konium chloride. Contact Dermatitis, 36 (2): 112 (1997).
  • Krysiak, B., K. Rydzynski, and M. Kiec-Swierczynska: Deena dzialania drazniacego i uczulajacego chlorku benzalkonium [The evaluation of the irritating and sensitiz-ing effects of benzalkonium chloride]. Med. Pr., 49 (4): 371–379 (1998).
  • Kryvorutchenko, I. L., I. S. Kryvoshein, I. B. Andronovs'ka, S. S. Marennykova, L. H. Stepanova, D. N. Nosyk, L. B. Kalnina, and A. P. Rud'ko: Antiseptic myramistin possesses the strong anti-HIV properties. Mikrobiol. Z., 58 (5): 90–92 (1996).
  • Kuboyama, Y., K. Suzuki, and T. Hara: Nasal lesions induced by intranasal adminis-tration of benzalkonium chloride in rats. J. Toxicol. Sci., 22 (2): 153–160 (1997).
  • Kucken, D., H. Feucht, and P. Kaulfers: Association of qacE and qacEDeltal with mul-tiple resistance to antibiotics and antiseptics in clinical isolates of Gram-negative bacteria. FEMS Microbiol. Lett., 183 (1): 95–98 (2000).
  • Kummerer, K., A. Eitel, U. Braun, P. Hubner, F. Daschner, G. Mascart, M. Milandri, F. Reinthaler, and J. Verhoef: Analysis of benzalkonium chloride in the effluent from European hospitals by solid-phase extraction and high-performance liquid chroma-tography with post-column ion-pairing and fluorescence detection. J. Chromatogr. A., 774 (1–2): 281–286 (1997).
  • Kunieda, T., Y. Hosono, and K. Sakata: Experimental studies on intestinal absorption following Martin's operation. Jpn. J. Surg., 11(6): 481–484 (1981).
  • Kunisada, T., K. Yamada, S. Oda, and O. Hara: Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology, 195 Suppl 2: 14–18 (1997).
  • Kuppens, E. V., C. A. de Jong, T. R. Stolwijk, R. J. de Keizer, and J. A. van Best: Effect of timolol with and without preservative on the basal tear turnover in glaucoma. Br. J. Ophthalmol., 79 (4): 339–342 (1995).
  • Kupper, R. W., B. Dewald, K. H. Jakobs, M. Baggiolini, and P. Giersehik: G-protein activation by interleukin 8 and related cytokines in human neutrophil plasma mem-branes. Biochem. J., 282 (Pt. 2): 429–434 (1992).
  • Kurihara, T., M. Sugita, S. Motai, and S. Kurashige: In vitro induction of chlorhexidine-and benzalkonium-resistance in clinically isolated Pseudomonas aeruginosa. Kansenshogaku Zasshi - J. Jpn. Assoc. Inf. Dis., 67 (3): 202–206 (1993).
  • Kurose, M. and K. Saeki: Histamine release induced by neurotensin from rat peritoneal mast cells. Eur. J. PharmacoL, 76 (2–3): 129–136 (1981).
  • Kurtoglu, S., H. Caksen, and M. H. Poyrazoglu: Neonatal poisonings in middle Anatolia of Turkey: an analysis of 72 cases. J. ToxicoL Sci., 25 (2): 115–119(2000).
  • Kushla, G. P., J. L. Zatz, O. H. Mills, Jr., and R. S. Berger: Noninvasive assessment of anesthetic activity of topical lidocaine formulations. J. PharmaceuL Sci., 82 (11): 1118–1122 (1993).
  • Lacour, J. P., J. Castanet, P. Boutte, and J. P. Ortonne: Antisepsie du cordon ombilical du nouveau-ne: enquete et recommandations. [Antiseptic treatment of the umbilical cord in newborns: survey and recommendations]. Arch. Pediatr., 6 (6): 631–634 (1999).
  • Lampe, M., R. Patarca, M. V. Iregui, and H. I. Cantor: Polyclonal B cell activation by Eta-1 and autoimmunity. J. ImmunoL, 147: 2902–2906 (1991).
  • Langsrud, S., and G. Sundheim: Factors influencing a suspension test method for antimicrobial activity of disinfectants. J. AppL MicrobioL, 85 (6): 1006–1012 (1998).
  • Langsrud, S., and G. Sundheim: Factors contributing to the survival of poultry associ-ated Pseudomonas spp. exposed to a quaternary ammonium compound. J. AppL MicrobioL, 82 (6): 705–712 (1997).
  • Langsrud, S., and G. Sundheim: Flow cytometry for rapid assessment of viability after exposure to a quaternary ammonium compound. J. AppL BacterioL, 81(4): 411–418 (1996).
  • Lapalus, P., M. Ettaiche, D. Fredj-Reygrobellet, D. Jambou, and P. P. Elena: Cyto-toxicity studies in ophthalmology. Lens Eye Toxicity Res., 7 (3–4): 231-242(1990).
  • LaRosa, G. J., J. P. Davide, K. Weinhold, J. A. Waterbury, A. T. Profy, J. A. Lewis, A. J. Langlois, G. R. Dreesman, R. N. Boswell, P. Shadduck, L. H. Holley, M. Karplus, D. P. Bolognesi, T. J. Matthews, E. A. Emini, and S. D. Putney: Conserved se-quence and structural elements in the human immunodeficiency virus type I princi-pal neutralizing determinant. Science, 249: 932–935 (1990).
  • Le Sellin, J., M. Drouet, J. C. Bonneau, and A. Sabbah: Allergy survey in genital con-tact derinatitis. Allergie et Immunologie, 23 (4): 127–128 (1991).
  • LeBoit, P., B. M. Egoert, M. H. Stoler, J. A. Strauchen, T. G. Berger, T. S. Benedict Yen, T. A. Bonfiglio, C. K. English, and D. J. Wear: Epithelioid- hemangioma-like vascular proliferation in AIDS: manifestation of cat scratch disease bacillus infec-tion? Lancet, 1: 960–963 (1988).
  • Lee, C. N., J. Robinson, G. Mazzara, Y. L. Cheng, M. Essex, and T. H. Lee: Contribu-tion of hypervariable domains to the conformation of a broadly neutralizing glyco-protein 120 epitope. AIDS Res. Hum. Retrov., 11(7): 777–781 (1995).
  • Lee, S., K. Sode, K. Nakanishi, J. L. Marty, E. Tamiya, and I. Karube: A novel micro-bial sensor using luminous bacteria. Biosensors Bioelectronics, 7 (4): 273–277 (1992).
  • Lee, Y. H. and V. H. Lee: Formulation influence on ocular and systemic absorption of topically applied atenolol in the pigmented rabbit. J. Ocular PhannacoL, 9 (1): 47–58 (1993).
  • Lehr, G. J., S. M. Yuen, and G. D. Lawrence: Liquid chromatographic determination of atropine in nerve gas antidotes and other dosage forms. J. AOAC InL, 78 (2): 339–343 (1995).
  • Leibovich, S. J., P. J. Polverini, H. M. Sheperd, D. M. Wiseman, V. Shively, and N. Nuseir: Macrophage-induced angiogenesis is mediated by tumor necrosis factor-al-pha. Nature, 329: 630–632 (1987).
  • Lemaitre, J. P., H. Echchannaoui, G. Michaut, C. Divies, and A. Rousset: Plasmid-me-diated resistance to antimicrobial agents among listeriae. J. Food Prot., 61(11): 1459–1464 (1998).
  • Lemp, M. A. and L. E. Zimmerman: Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride. Am. J. OphthalmoL, 105 (6): 670–673 (1988).
  • Leow, M. E., A. K. Kour, T. J. Inglis, G. Kumarasinghe, and R. W. Pho: Fungal colo-nisation in digital silicone rubber prostheses. ProstheL OrthoL InL, 21(3): 195–198 (1997).
  • Leprat, R., P. Minary, V. Devaux, B. de Waziere, J. L. Dupond, and D. Talon: Why, when and how to clean stethoscopes. Hosp. Infect., 39 (1): 80–82 (1998).
  • Lesnik, R. H., L. H. Kligman, and A. M. Kligman: Agents that cause enlargement of sebaceous glands in hairless mice. 1. Topical substances. Arch. DermatoL Res., 284 (2): 100–105 (1992).
  • Levin, R. J.: Actions of spermicidal and virucidal agents on electrogenic ion transfer across human vaginal epithelium in vitro. PharmacoL ToxicoL, 81(5): 219–225 (1997).
  • Levrat, F., P. J. Pisella, and C. Baudouin: Tolerance clinique des collyres anti-glaucomateux conserves et non conserves. Resultats d'une enquete inedite en Eu-rope [Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe]. J. Fr. OphtalmoL, 22 (2): 186–191 (1999).
  • Li, C., X. Zhang, and R. Whitboume: In vitro antimicrobial activity of a new antiseptic central venous catheter. J. Biomater. AppL, 13 (3): 206–223 (1999).
  • Li, M., J. Yang, G. X. Shen, Q. Zhang, S. P. Liu, Z. B. Liu, and W. X. Ye: Study on lymphocyte activation and proliferation induced by anti-CD3 MoAb. J. Tongii Med. Univ., 14 (4): 209–212 (1994).
  • Li, Y, and C. Owyang: Peptone stimulates CCK-releasing peptide secretion by activat-ing intestinal submucosal cholinergic neurons. J. CIM. Invest., 97 (6): 1463–1470 (1996).
  • Li, Z. L., M. L. Li, F. Qian, L. M. Shi, and R. Q. Yu: Kalman filtering-titrimetry: potentiometric titration of benzalkonium bromide. Yao Hsueh Hsueh Pao - Acta Phamwceutica Sinica, 25 (1): 35–43 (1990).
  • Lim, K. G., H.-C. Wan, P. T. Bozza, M. B. Resnick, D. T. W. Wong, W. W. Cruikshank, H. Komfeld, D. M. Center, and P. F. Weller: Human eosinophils elaborate the lym-phocyte chemoattractants IL-16 (lymphocyte chemoattractant factor) and RANTES. J. ImmunoL, 156: 2566–2570 (1996).
  • Lin, C. P., and M. Boehnke: Influence of rigid gas permeable contact lens solutions on corneal epithelial wound healing. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih, 13 (9): 562–565 (1997).
  • Lin, C. P. and M. Boehnke: A new model for in vitro corneal epithelial wound healing study. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih, 13 (8): 475–479 (1997).
  • Lovell, C. R. and P. Staniforth: Contact allergy to benzalkonium chloride in plaster of Paris. Contact Dermatitis, 7 (6): 343–344 (1981).
  • Lovely, T. J., D. E. Levin, and E. Klekowski: Light-induced genetic toxicity of thimerosal and benzalkonium chloride in commercial contact lens solutions. MutaL Res., 101 (1): 11–18 (1982).
  • Lucci, L. M., M. C. Yu, and A. L. Hofling-Lima: Decontamination of human sclera: an in vitro study. Cornea, 18 (5): 595–598 (1999).
  • Lumbroso, P., M. Nhamias, S. Nhamias, and P. Tranche: A preliminary study of the adsorption and release of preservatives by contact lenses and collagen shields. CLAO J., 22 (1): 61–63 (1996).
  • Lyons, J. M., and J. I. Jr. Ito: Reducing the risk of Chlamydia trachomatis genital tract infection by evaluating the prophylactic potential of vaginally applied chemicals. Clin. Infect. Dis., 21 Suppl 2: S174-S177 (1995).
  • MacKeen, D. L.: Effects of aqueous instillation. Ophthalmology, 106 (10): 1853 (1999).
  • MacNeish, C. F., D. Meisner, R. Thibert, S. Kelemen, E. B. Vadas, and A. L. Coates: A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) respirator solution. Chest, 111(1): 204–248 (1997).
  • Madhu, C., P. J. Rix, M. J. Shackleton, T. G. Nguyen, and D. D. Tang-Liu: Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac trometh-amine following ocular instillation to normal and de-epithelialized corneas of rab-bits. J. Pharm. Sci., 85 (4): 415–418 (1996).
  • Maghazachi, A. A. and A. Al-Aoukaty: Gs is the major G protein involved in interleukin-2-activated natural killer (LANK) cell-mediated cytotoxicity. Success-ful introduction of anti-G protein antibodies inside streptolysin 0-permeabilized TANK cells. J. Biol. Chem., 269 (9): 6796–6802 (1994).
  • Maillard, J. Y., S. Messager, and R. Veillon: Antimicrobial efficacy of biocides tested on skin using an ex-vivo test. J. Hosp. Infect., 40 (4): 313–323 (1998).
  • Majtan, V. and L. Majtanova: The effect of new disinfectant substances on the metabo-lism of Enterobacter cloacae. Int. J. Antimicrob. Agents, 11(1): 59–64 (1999).
  • Makino, M., M. Kurose, Y. Sasada, H. Zenda, and S. Ohta: Synthesis of new anfimsty disinfectants. Yakugaku Zasshi—J. PharmaceuL Soc. Japan, 112 (10): 712–722 (1992).
  • Makino, M., S. Ohta, and H. Zenda: Study on new anti-rust disinfectants. III. Effect of alkyl chain length of N- alkyl-N-(2-hydroxy-3-phenoxy)propyl-N,N-dimethyl- ammo-nium butyl phosphate on the antibacterial activity. Yakugaku Zasshi—J. PharmaceuL Soc. Japan, 114 (2): 13–79 (1994).
  • Manetz, T. S., and B. J. Meade: Development of a flow cytometry assay for the identi-fication and differentiation of chemicals with the potential to elicit irritation, IgE-mediated, or T cell-mediated hypersensitivity responses. Toxico1 Sci., 48 (2): 206–217 (1999).
  • Marcozzi, G., C. Di Domenico, and N. Spreti: Effects of surfactants on the stabilization of the bovine lactoperoxidase activity. Biotechnol. Prog., 14 (4): 653–656 (1998).
  • MarineIla, M. A., C. Pierson, and C. Chenoweth: The stethoscope. A potential source of nosocomial infection? Arch. Intern. Med., 157 (7): 786–790 (1997).
  • Martin, L. S., J. S. McDougal, and S. L. Loskoski: Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J. Inf. Dis., 152: 400–403 (1985).
  • Mattsson, E., H. Van Dijk, K. Van Kessel, J. Verhoef, A. Fleer, and J. Rollof: Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar. J. Inf. Dis., 173 (1): 212–218 (1996).
  • Mauck, C. K., J. M. Baker, S. P. Barr, T. J. Abercrombie, and D. F. Archer: A phase I comparative study of contraceptive vaginal films containing benzalkonium chlo-ride and nonoxyno1-9. Postcoital testing and colposcopy. Contraception, 56 (2): 89–96 (1997).
  • Maudgal, P. C., H. Cornelis, and L. Missotten: Effects of commercial ophthalmic drugs on rabbit corneal epithelium. A scanning electron-microscopic study. Albrecht Von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie, 216 (3): 191–203 (1981).
  • May, L. L., M. M. Gabriel, R. B. Simmons, L. A. Wilson, and D. G. Ahearn: Resistance of adhered bacteria to rigid gas permeable contact lens solutions. CLAO J., 21(4): 242–246 (1995).
  • McCarthy, T. J. and J. H. Ferreira: Attempted measurement of the activity of selected preservative combinations. J. Clin. Phann. TherapeuL, 15 (2): 123–129 (1990).
  • McFadden, J. P., D. B. Holloway, E. G. Whittle, and D. A. Basketter: Benzalkonium chloride neutralizes the irritant effect of sodium dodecyl sulfate. Contact Dermati-tis, 43 (5): 264–266 (2000).
  • McMahon, C., Y. Darby, R. Ryan, and G. Scadding: Immediate and short-term effects of benzalkonium chloride on the human nasal mucosa in vivo. Clin. OtolaryngoL, 22 (4): 318–322 (1997).
  • Meier, U.-C., P. Kienerman, P. Griffin, W. James, B. Koppe, B. Larder, A. McMichael, and R. Phillips: Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Sci-ence, 270: 1360–1362 (1995).
  • Menendez, R., R. S. Lowe, and J. Kersey: Benzalkonium chloride and broncho-constriction. J. Allergy Clin. ImmunoL, 84 (2): 272–274 (1989).
  • Mendez, F., A. Castro, and A. Ortega: Use effectiveness of a spermicidal suppository containing benzalkonium chloride. Contraception, 34 (4): 353–362 (1986).
  • Merrill, J. E., Y. Koyanagi, and I. S. Y. Chen: Interleukin-1 and tumor necrosis factor can be induced from mononuclear phagocytes by human immunodeficiency virus type I binding to the CD4 receptor. J. ViroL, 63: 4404–4408 (1989).
  • Meyer, R. C.: Determination of benzalkonium chloride by reversed-phase high-pres-sure liquid chromatography. J. Pharm. Sci., 69 (10): 1148–1150 (1980).
  • Meyer, U., I. Gerhard, and B. Runnebaum: Benzalkonium chloride for vaginal contra-ception—the vaginal sponge. Geburtshilfe und Frauenheilkunde, 50 (7): 542–547 (1990).
  • Miampamba, M., E. J. Parr, D. M. McCafferty, J. L. Wallace, and K. A. Sharkey: Ef-fect of intracolonic benzalkonium chloride on trinitrobenzene sulphonic acid-in-duced colitis in the rat. Aliment PharmacoL Ther., 12 (3): 219–228 (1998).
  • Mietz, H., U. Niesen, and G. K. Krieg'stein: The effect of preservatives and anti-glaucomatous medication on the histopathology of the conjunctiva. Graefes Arch. ClM. Exp. OphthalmoL, 232 (9): 561–565 (1994).
  • Mimoz, O., L. Pieroni, C. Lawrence, A. Edouard, Y. Costa, K. Samii, and C. Brun-Buisson: Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Grit. Care Med., 24(11): 1818–1823 (1996).
  • Minakuchi, K., Y. Yamamoto, K. Matsunaga, M. Hayata, T. Yasuda, Y. Katsuno, H. Takada, J. Hiyama, S. Ishigo, and Y. Asano: The antiseptic effect of a quick drying rubbing type povidone-iodine alcoholic disinfectant solution. Posgrad. Med. J., 69 (Suppl. 3): S23-S26 (1993).
  • Miszkiel, K. A., R. Beasley, and S. T. Holgate: The influence of ipratmpium bromide and sodium chromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma. Br. J. ClM. PharmacoL, 26 (3): 295–301 (1988a).
  • Miszkiel, K. A., R. Beasley, P. Rafferty, and S. T. Holgate: The contribution of hista-mine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma. Br. J. ClM. PharmacoL, 25 (2): 157–163 (1988b).
  • Mittrucker, H. W. and B. Fleischer: Functional localization of an exocytosis-triggering G-protein in human cytotoxic T lymphocytes. Immunology, 76(4): 610–615 (1992).
  • Mitchell, B. A., I. T. Paulsen, M. H. Brown, and R. A. Skurray: Bioenergetics of the staphylococcal multidrug export protein QacA. Identification of distinct binding sites for monovalent and divalent cations. J. Biol. Chem., 274 (6): 3541–3548 (1999).
  • Mochizuki, H. and M. Sugiyama: Prevention and treatment of MRSA infection in emergency surgical ward. Nippon Geka Gakkai Zasshi—J. Jpn. Surg. Soc., 93 (9): 902–905 (1992).
  • Moldenhauer, D.: Quantitative evaluation of the effects of disinfectants against viruses in suspension experiments. Zentralblatt.fur Bakteriologie, Mikrobiologie und Hy-giene-I-Abt-Originale B, Hygiene, 179 (6): 544–554 (1984).
  • Momma, J., K. Takada, Y. Aida, A. Takagi, H. Yoshimoto, Y. Suzuki, Y. Nakaji, Y. Kurokawa, and M. Tobe: Effects of benzalkonium chloride on pregnant mice. Eisei Shikenjo Hokoku—Bull. Nat. Inst. Hyg. Sci., 105: 20–25 (1987).
  • Momose, T., N. Ito, A. Kanai, Y. Watanabe, and M. Shibata: Adsorption of levo-cabastine eye drops by soft contact lenses and its effects in rabbit eyes. CLAO J., 23 (2): 96–99 (1997).
  • Moore, M. B.: Acanthamoeba keratitis and contact lens wear: the patient is at fault. Cornea, 9\(Suppl. 1):533- S35 (1990).
  • Montrucchio, G., E. Lupia, E. Battaglia, G. Passerini, F. Bussolino, G. Emanuelli, and G. Camussi: Tumor necrosis factor-a-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med., 180: 377–382 (1994).
  • Moran, J., M. Addy, R. Jackson, and R. G. Newcombe: Comparative effects of quater-nary ammonium mouthrinses on 4-day plaque regrowth. J. Clin. PeriodontoL, 27 (1): 37–40 (2000).
  • More, D. R., J. S. Seidel, and P. A. Bryan: Ear-piercing techniques as a cause of auricu-lar chondritis. Pediatr. Emerg. Care, 15 (3): 189–192 (1999).
  • Moreno, J. J.: Arachidonic acid release and prostaglandin E2 synthesis as irritant index of surfactants in 3T6 fibroblast cultures. Toxicology, 143 (3): 275–282 (2000).
  • Mori, K., C. Maru, K. Takasuna, and K. Furuhama: Mechanism of histamine release induced by levofloxacin, a fluoroquinolone antibacterial agent. Eur. J. PharmacoL, 394(1): 51–55 (2000).
  • Moricz, K., B. Gyetvai, and G. Bardos: Morphological and functional changes after benzalkonium chloride treatment of the small intestinal Thiry-Vella loop in rats. Brain Res. Bull., 46(6): 519–528 (1998).
  • Morimoto, K., Y. Uehara, K. Iwanaga, M. Kakemi, Y. Ohashi, A. Tanaka, and Y. Nakai: Influence of absorption enhancers (bile salts) and the preservative (benzal-konium chloride) on mucociliary function and permeation barrier function in rabbit tracheas. Eur. J. Pharm. Sci., 6 (3): 225–230 (1998).
  • Morrell, J. M.: Techniques of embryo transfer and facility decontamination used to im-prove the health and welfare of transgenic mice. Lab. Anim., 33 (3): 201–206 (1999).
  • Moss, H. A., S. E. Tebbs, M. H. Faroqui, T. Herbst, J. L. Isaac, J. Brown, and T. S. Elliott: A central venous catheter coated with benzalkonium chloride for the pre-vention of catheter-related microbial colonization. Eur. J. AnaesthesioL, 17 (11): 680–687 (2000).
  • Moss, J. N.: Reconciling clinical data with risk: the Kathon® biocide story. Occupa-tional Med., 9 (1): 113–119 (1994).
  • Motai, S., T. Kurihara, M. Sugiita, and S. Kurashige: Relationship between hand-washing activity of disinfectants and in vitro bactericidal activity in the presence of peptone. Kansenshogaku Zasshi—J. Jpn. Assoc. Inf. Dis., 66(11): 1532–1537(1992).
  • Mousli, M., T. E. Hugh, Y. Landry, and C. Bronner: A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J. ImmunoL, 148 (8): 2456–2461 (1992).
  • Mousli, M. and Y. Landry: Role of positive charges of neuropeptide Y fragments in mast cell activation. Agents Actions, 41: C41–C42 (1994).
  • Mousli, M., A. Trifilieff, J. T. Pe1ton, J. P. Gies, and Y. Landry: Structural require-ments for neuropeptide Y in mast cell and G protein activation. Eur. J. PharmacoL, 289 (1): 125–133 (1995).
  • Moussa, F. W., B. J. Gainor, J. O. Anglen, G. Christensen, and W. A. Simpson: Disin-fecting agents for removing adherent bacteria from orthopaedic hardware. Clin. Orthop., 329: 255–262 (1996).
  • Msellati, P., N. Meda, V. Leroy, R. Likikouet, P. Van de Perre, M. Cartoux, D. Bonard, A. Ouangre, P. Combe, L. Gautier-Charpentier, F. Sylla-Koko, R. LassaIle, M. Dosso, C. Welffens-Ekra, F. Dabis, and L. Mandelbrot: Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV infected pregnant women in west Africa: ANRS 049b phase II randomized, double blinded placebo controlled trial. DITRAME Study Group. Sex. Transm. Infect., 75 (6): 420–425 (1999).
  • Mukaida, N.: A newly discovered chemotactic factor for neutrophil: interleukin-8. Rinsho Byori—Jpn. J. Clin. PathoL, 40 (4): 371–379 (1992).
  • Muller-Decker, K., G. Furstenberger, and F. Marks: Keratinocyte-derived proinflam-matory key mediators and cell viability as in vitro parameters of irritancy: a possible alternative to the Draize skin irritation test. ToxicoL AppL PharmacoL, 127 (1): 99–108 (1994).
  • Muller-Decker, K., T. Heinzelmann, G. Furstenberger, A. Kecskes, W. D. Lehmann, and F. Marks: Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants. ToxicoL AppL PharmacoL, 153 (1): 59–67 (1998).
  • Murai, S., S. Imajo, H. Inumaru, K. Takahashi, and K. Hattori: Adsorption and recov-ery of ionic surfactants by beta-cyclodextrin polymer. J. Colloid Interface Sci., 190 (2): 488–490 (1997).
  • Murphy, P. M.: The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. ImmunoL, 12: 593–633 (1994).
  • Murray, P. R., R. L. Heeren, and A. C. Niles: Effect of decontamination procedures on recovery of Nocardia spp. J. ClM. MicrobioL, 25 (10): 2010–2011 (1987).
  • Murray, P. R., A. C. Niles, and R. L. Heeren: Modified Thayer-Martin medium for re-covery of Nocardia species from contaminated specimens. J. Clin. MicrobioL, 26 (6): 1219–1220 (1988).
  • Muszynski, Z. and J. Dlugaszewska: Antimicrobial conservation of some cosmetics. Medycyna Doswiadczaina i Mikrobiologia, 46(1-2): 87–90 (1994).
  • Nagai, I. and H. Ogase: Absence of role for plasmids in resistance to multiple disinfec-tants in three strains of bacteria. J. Hosp. Inf., 15 (2): 149–155 (1990).
  • Nagai, K., S. Ohta, H. Zenda, H. Matsumoto, and M. Makino: Biochemical character-ization of a Pseudomonas fluorescens strain isolated from a benzalkonium chloride solution. Biol. Pharm. Bull., 19 (6): 873–875 (1996).
  • Nagamune, H., T. Maeda, K. Ohkura, K. Yamamoto, M. Nakajima, and H. Kourai: Evaluation of the cytotoxic effects of bis-quaternary ammonium antimicrobial re-agents on human cells. ToxicoL Vitr., 14 (2): 139–147 (2000).
  • Nakahori, Y., C. Katakami, and M. Yamamoto: Corneal endothelial cell proliferation and migration after penetrating keratoplasty in rabbits. Jpn. J. OphthalmoL, 40 (2): 271–278 (1996).
  • Nakao, M., K. Yokota, K. Oguma, and K. Takai: [The bacteriocidal effect of the elec-trolysed functioning water against Helicobacter pylori]. Kansenshogaku Zasshi, 74 (2): 120–127 (2000).
  • Nakashima, A. K., M. A. McCarthy, W. J. Marione, and R. L. Anderson: Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic. J. Clin. MicrobioL, 25 (6): 1014–1018 (1987a).
  • Nakashima, A. K., A. K. Highsmith, and W. J. Marione: Survival of Serratia marcescens in benzalkonium chloride and in multiple-dose medication vials: relationship to ep-idemic septic arthritis. J. Clin. MicrobioL, 25 (6): 1019–1021 (1987b).
  • Neuberger, T. J., C. M. Wittgen, T. A. Schneider, II, C. H. Andrus, W. M. Panneton, and D. L. Kaminski: Evaluation of alternative proximal gastric vagotomy tech-niques after a 9-month interval in a rat model. Gastrointest. Endosc., 40 (3): 316–320 (1994).
  • Nguyen, T. P., J. H. Nishimoto, C. Y. Nakamura, and P. N. De Land: Comparison of carboxymethylcellulose vs. hydroxypropyl methylcellulose as a gonioscopic fluid. Optom. Vis. Sci., 73 (7): 466–472 (1996).
  • Nicander, I., S. 011mar, A. Eek, B. Lundh Rozell, and L. Emtestam: Correlation of im-pedance response patterns to histological findings in irritant skin reactions induced by various surfactants. Br. J. DermatoL, 134 (2): 221–228 (1996).
  • Nishigaki, N., M. Negishi, Y. Sugimoto, T. Namba, S. Narumiya, and A. Ichikawa: Characterization of the prostaglandin E receptor expressed on a cultured mast cell line, Bnu-2c13. Biochem. PharmacoL, 46 (5): 863–869 (1993).
  • Niszl, I. A., and M. B. Markus: Anti-acanthamoeba activity of contact lens solutions. Br. J. OphthalmoL, 82 (9): 1033–1038 (1998).
  • Niitsuma, A., M. K. Uchida, and T. Suzuki-Nishimura: Benzalkonium chloride inhib-ited the histamine release from rat peritoneal mast cells induced by bradykinin and GleNAc oligomer-specific lectin Datura stramonium agglutinin, but heparin did not. Gen. PharmacoL, 27 (1): 123–128 (1996).
  • Novello, W. P., M. H. Santana, and A. C. Fonseca De Arruda: In vitro evaluation of open heart surgery tubing coated with heparin and lipid. Artif. Organs, 24 (3): 182–184 (2000).
  • Nowak, M. A., R. M. Anderson, A. R. McLean, T. F. Wolfs, J. Goudsmit, and R. M. May: Antigenic diversity thresholds and the development of AIDS. Science, 254: 963–969 (1991).
  • Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Kienerman, B. Koppe, K. Sigmund, C. R. Bangham, et al.: Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature, 375: 606–611 (1995).
  • Ntsama-Essomba, C., S. Bouttier, M. RamaIdes, F. Dubois-Brissonnet, and J. Fourniat: Resistance of Escherichia coli growing as biofilms to disinfectants. Vet. Res., 28 (4): 353–363 (1997).
  • Nuzzi, R., C. Finazzo, and A. Cerruti: Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal response. InL OphthalmoL, 22 (1): 31–35 (1998).
  • O'Brien, W. J., J. D. Carlo, M. Stem, and R. A. Hyndiuk: Effects of timoptic on corneal reepithelialization. Arch. Ophthalmol„ 100 (8): 1331–1333 (1982).
  • O'Connor, T. J., D. Kinchington, H. O. Kangro, and D. J. Jeffries: The activity of can-didate virucidal agents, low pH and genital secretions against HIV-1 in vitro. InL J. STD AIDS, 6(4): 267–272 (1995).
  • Ohmura, T., A. Sakata, and K. Onoue: A 68-1(D GTP-binding protein associated with the T cell receptor complex. J. Exp. Med., 176 (3): 887–891 (1992).
  • Ohta, S., M. Makino, K. Nagai, and H. Zenda: Comparative fungicidal activity of a new quaternary ammonium salt, N-alkyl-N-2-hydroxyethyl-N,N-dimethylammon-ium butyl phosphate and commonly used disinfectants. Biol. Pharm. Bull., 19 (2): 308–310 (1996).
  • Oie, S. and A. Kamiya: Microbial contamination of antiseptics and disinfectants. Am. J. Infect. Control, 24 (5): 389–395 (1996).
  • Oie, S., Y. Huang, A. Kamiya, H. Konishi, and T. Nakazawa: Efficacy of disinfectants against biofilm cells of methicillin-resistant Staphylococcus aureus. Microbios, 85 (345): 223–230 (1996).
  • Oie, S. and A. Kamiya: Microbial contamination of antiseptic-soaked cotton balls. Biol. Pharm. Bull., 20 (6): 667–669 (1997).
  • Oie, S. and A. Kamiya: Microbial contamination of benzalkonium chloride products. Am. J. Health SysL Pharm., 55 (23): 2534, 2537 (1998).
  • Oie, S., A. Kamiya, M. Tomita, A. Katayama, A. Iwasaki, and S. Miyamura: Efficacy of disinfectants and heat against Escherichia coli 0157:H7. Microbios, 98 (389): 7–14 (1999).
  • Oie, S., A. Kamiya, T. Seto, A. Suga, and K. Naito: Microbial contamination of in-use lubricants for non-touch urethral catheters in intermittent self-catheterization. Biol. Pharm. Bull., 23 (6): 781–783 (2000).
  • Olson, R. K., R. E. Voorhees, H. E. Eitzen, H. Rolka, and C. M. Sewell: Cluster of postinjection abscesses related to corticosteroid injections and use of benzalkonium chloride. West. J. Med., 170 (3): 143–147 (1999).
  • Opperman, R. V.: The effect of some cationic antiseptics on the acidogenicity of denw plaque in vivo. Acta OdontoL Scand., 38 (3). 155–161 (1980).
  • Ortiz-Frutos, F. J., D. Argila, R. Rivera, O. Zamarro, and S. Miguelez: Allergic contact dermatitis from benzalkonium chloride used as a denaturant of ethanol. Contact Dermatitis, 35 (5): 302 (1996).
  • Ovchinnikov, A. A., S. A. Dratvin, and L. V. Pilavina: On the methods of disinfecting bronchofibroscopes. J. Hygiene EpidemioL MicrobioL ImmunoL, 34 (4): 371–379 (1990).
  • Paesen, J., I. Quintens, G. Thoithi, E. Roets, G. Reybrouck, and J. Hoogmartens: Quan-titative analysis of quaternary ammonium antiseptics using thin-layer densitometry. J. Chromatog. A., 677 (2): 377–384 (1994).
  • Pallanza, R., R. Scotti, G. Beretta, B. Cavalleri, and V. Arioli: In vitro activity of A-16686, a potential antiplaque agent. Antimicrob. Agents Chemother., 26 (4): 462–465 (1984).
  • Palmberg, R., Y. S. Gutierrez, D. Miller, W. J. Feuer, and D. R. Anderson: Potential bacterial contamination of eyedrops used for tonometry. Am. J. OphthalmoL, 117 (5): 578–582 (1994).
  • Pandey, A., H. Shao, R. M. Marks, P. J. Polverini, and V. M. Dixit: Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-a-induced angiogenesis. Sci-ence, 268: 567–569 (1995).
  • Park, K. B. and H. C. Enn: A study of skin responses to follow-up, rechallenge and combined effects of irritants using non-invasive measurements. J. DermatoL Sci., 10 (2): 159–165 (1995).
  • Park, H. J., H. A. Kang, J. Y. Lee, and H. O. Kim: Allergic contact dermatitis from benzalkonium chloride in an antifungal solution. Contact Dermatitis, 42(5): 306–307 (2000).
  • Park, K. B., and H. C. Eun: A study of skin responses to follow-up, rechallenge and combined effects of irritants using non-invasive measurements. J. DermatoL Sci., 10 (2): 159–165 (1995).
  • Parkin, J. E.: The assay of benzalkonium chloride in pilocarpine, hypromellose and polyvinyl alcohol ophthalmic drops by second-order derivative ultraviolet spectro-photometry. J. PharmaceuL Biomed. Anal., 11(7): 609–611 (1993).
  • Parnigotto, P. P., V. Bassani, F. Montesi, and M. T. Conconi: Bovine corneal stroma and epithelium reconstructed in vitro: characterisation and response to surfactants. Eye, 12 (Pt 2): 304–310 (1998).
  • Parr, E. J., and K. A. Sharkey: Multiple mechanisms contribute to myenteric plexus ab-lation induced by benzalkonium chloride in the guinea-pig ileum. Cell Tissue Res., 289 (2): 253–264 (1997).
  • Patarca, R. and W. A. Haseltine: Variation among the human T-Iymphotropic virus type III (HTLV-III/LAV) strains. J. Theor. Biol., 125: 213–217 (1986).
  • Patarca, R., G. J. Freeman, R. P. Singh, F.-Y. Wei, T. Durfee, F. Blattner, D. C. Regnier, C. A. Kozak, B. A. Mock, H. C. Morse, III, T. R. Jerrells, and H. Cantor: Structural and functional studies of the early T lymphocyte activation I (Eta-1) gene. Definition of a novel T-cell-dependent response associated with genetic resis-tance to bacterial infection. J. Exp. Med., 170: 145–161 (1989).
  • Patarca, R., F.-Y. Wei, P. Singh, M. I. Morasso, and H. Cantor: Disregulated expres-sion of the T-cell cytokine Eta-1 in CD4-8-lymphocytes during the development of murine autoimmune disease. J. Exp. Med., 172: 1177–1183 (1990).
  • Patarca, R., R. A. Saavedra, and H. Cantor: Molecular and cellular basis of genetic re-sistance to bacterial infection: The role of the early T-lymphocyte activation-1/ osteopontin gene. CriL Rev. ImmunoL, 13 (3/4): 225–246 (1993).
  • Patarca, R. and M. A. Fletcher: Effects of benzalkonium salts on eukaryotic and micro-bial G-protein-mediated processes and surface membranes. CriL Rev. Oncog., 6 (3–6): 327–356 (1995a).
  • Patarca, R., D. Sandler, J. Walling, N. G. Klimas, and M. A. Fletcher: Assessment of immune mediator expression levels in biological fluids and cells: a critical ap-praisal. Grit. Rev. Oncog., 6(2): 117–149 (1995b).
  • Patarca, R., M. A. Fletcher, and E. R. Podack: Cytolytic cell functions. In: Manual of Clinical Laboratory Immunology. Rose, N. R., E. C. de Macario, J. D. Folds, H. C. Lane, and R. M. Nakamura (Eds.) 5th edition, American Society for Microbiology, Washington, D.C. (1996).
  • Patrick, E., H. I. Maibach, and A. Burkhalter: Mechanisms of chemically induced skin irritation. 1. Studies of time course, dose response, and components of inflamma-tion in the laboratory mouse. Toxico1 AppL PharmacoL, 81 (3 Pt 1): 476–490 (1985).
  • Patton, D. L., G. G. Kidder, Y. C. Sweeney, L. K. Rabe, and S. L. Hillier: Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epi-thelium in the pigtailed macaque (Macaca nemestrina). Am. J. ObsteL GynecoL, 180 (5): 1080–1087 (1999).
  • Patton, D. L., Y. C. Sweeney, L. K. Rabe, and S. L. Hillier: The vaginal microflora of pig-tailed macaques and the effects of chlorhexidine and benzalkonium on this eco-system. Sex. Transm. Dis., 23 (6): 489–493 (1996).
  • Paugh, J. R., A. Sasai, and A. Joshi: Preservative effect on epithelial barrier function measured with a novel technique. Adv. Exp. Med. Biol., 438: 731–735 (1998).
  • Pereira, M. S. and J. P. Siqueira-Junior: Antimicrobial drug resistance in Staphylococ-cus aureus isolated from cattle in Brazil. Lett. AppL MicrobioL, 20 (6): 391–395 (1995).
  • Perrenoud, D., A. Bircher, T. Hunziker, H. Suter, L. Bruckner-Tuderman, J. Stager, W. Thurlimann, P. Schniid, A. Suard, and N. Hunziker: Frequency of sensitization to 13 common preservatives in Switzerland. Swiss Contact Dermatitis Research Group. Contact Dermatitis, 30 (5): 276–279 (1994).
  • Persico, P., A. Calignano, F. Mancuso, and L. Sorrentino: Involvement of NK recep-tors and beta-adrenoreceptors in nitric oxide-dependent relaxation of rabbit aorta rings following electrical-field stimulation. Eur. J. PharmacoL, 238 (1): 105–109 (1993).
  • Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangharn, C. R. Rizza, and A. J. McMichael: Human immunodeficiency virus genetic variation that can escape cytotoxic T-cell recognition. Nature, 354: 453–459 (1991).
  • Pigret, D. and R. Jankowski: Management of post-ethmoidectomy crust formation: randomized single-blind clinical trial comparing pressurized seawater versus anti-septic/mucolytic saline. Rhinology, 34 (1): 38–40 (1996).
  • Pinzauti, S., E. La Porta, and M. Casini: Potentiometric microdetermination of benzal-konium content of the hard contact lens solutions marketed in Italy. Bolletino Chimico Farmaceutico, 120 (1): 43–48 (1981).
  • Piotrowski, W. and J. C. Foreman: On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Naunyn- Schmiedebergs Arch. PharmacoL, 331 (4): 364–368 (1985).
  • Pisella, P. J., K. Fillacier, P. P. Elena, C. Debbasch, and C. Baudouin: Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular sur-face of albino rabbits. Ophthalmic. Res., 32 (1): 3–8 (2000).
  • Placucci, F., A. Benini, L. Guerra, and A. Tosti: Occupational allergic contact dermati-tis from disinfectant wipes used in dentistry. Contact Dermatitis, 35 (5): 306 (1996).
  • Platt, J. and R. A. Buckna: An experimental evaluation of antiseptic wound irrigation. J. Hosp. Infect., 5 (2): 181–188 (1984).
  • Podder, S. K., K. C. Moy, and V. H. Lee: Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition. Exp. Eye Res., 54 (5): 747–757 (1992).
  • Polat, S., N. Ozdemir, M. Soylu, U. Mete, Z. Unlugenc, and M. Kaya: Ultrastructural effects of topical beta-adrenergic antagonists and an alpha-adrenergic agonist on the rabbit cornea. Ophthalmologica, 213 (3): 183–188 (1999).
  • Ponder, R. D. and B. B. Wray: A case report: sensitivity to benzalkonium chloride. J. Asthma, 30(3): 229–231 (1993).
  • Pons, J. L., N. Bonnaveiro, J. Chevalier, and A. Creniieux: Evaluation of antimicrobial interactions between chlorhexidine, quaternary ammonium compounds, preserva-tives and excipients. J. AppL BacterioL, 73 (5): 395–400 (1992).
  • Primor, N.: Action on ileal smooth muscle of synthetic detergents and pardaxin. Gen-eral PharmacoL, 17 (4): 413–418 (1986).
  • Prince, S. J., H. J. McLaury, L. V. Allen, and P. McLaury: Analysis of benzalkonium chloride and its homologs: HPLC versus HPCE. J. Pharm. Biomed. Anal., 19 (6): 877–882 (1999).
  • Psychoyos, A., G. Creatsas, E. Hassan, V. Georgoulias, and A. Gravanis: Spermicidal and antiviral properties of a new vaginal sponge (Protectaid) containing sodium cholate. Hum. ReproducL, 8 (6): 866–869 (1993).
  • Purohit, A., M. C. Kopferschmitt-Kubler, C. Moreau, E. Popin, M. Blaumeiser, and G. Pauli: Quaternary ammonium compounds and occupational asthma. InL Arch. Occup. Environ. Health, 73 (6): 423–427 (2000).
  • Quinnan, G. V., M. A. Wells, A. E. Wittek, M. A. Phelan, R. E. Mayner, S. Feinstone, R. H. Purcell, and J. S. Epstein: Inactivation of the human T lymphotropic virus type III by heat, chemicals and irradiation. Transfusion, 26: 481–483 (1986).
  • Raith, K., E. Althoff, J. Banse, H. Neidhardt, and R. H. Neubert: Two examples of rapid and simple drug analysis in pharmaceutical formulations using capillary elec-trophoresis: naphazoline, dexamethasone and benzalkonium in nose drops and nystatin in an oily suspension. Electrophoresis, 19 (16–17): 2907-2911(1998).
  • Ramalho, F. S., G. C. Santos, L. N. Ramalho, J. K. Kajiwara, and S. Zueoloto: Myenteric neuron number after acute and chronic denervation of the proximal jeju-num induced by benzalkonium chloride. Neurosci. Lett., 163 (10): 74–76 (1993).
  • Ramalho, F. S., G. C. Santos, L. N. Ramalho, J. K. Kajiwara, and S. Zucoloto: Jejuna' myenteric denervation induced by benzalkonium chloride. Arquivos de Gastro-enterologia, 31(1): 24–29 (1994).
  • Ramer, J. C., J. Paul-Murphy, D. Brunson, and C. J. Murphy: Effects of mydriatic agents in cockatoos, African gray parrots, and blue-fronted Amazon parrots. J. Am. Vet. Med. Assoc., 208 (2): 227–230 (1996).
  • Ray, K., N. Thompson, N. Kennard, P. Rollins, S. Grenfell, S. Witham, N. Smithers, and R. Solari: Investigation of guanine-nucleotide-binding protein involvement and regulation of cyclic AMP metabolism in interleukin-1 signal transduction. Biochem. J., 282 (Pt. 1): 59–67 (1992).
  • Read, G. W., S. M. Hong, and E. F. Kiefer: Competitive inhibition of 48/80-induced histamine release by benzalkonium chloride and its analogs and the polyamine re-ceptor in mast cells. J. PharmacoL Exp. Therapeut., 222 (3): 652–657 (1982).
  • Rees, E. N., S. E. Tebbs, and T. S. Elliott: Role of antimicrobial-impregnated polymer and teflon in the prevention of biliary stent blockage. J. Hosp. Infect., 39 (4): 323–329 (9198).
  • Relman, D. A., P. W. Lepp, K. N. Sadler, and T. M. Schmidt: Phylogenetic relation-ships among the agent of bacillary angiomatosis, Bartonella bacilliformis, and other alpha-proteobacteria. MoL MicrobioL, 6 (13): 650–657 (1992).
  • Renner, P. and J. Peters: Resistance of enterococci to heat and chemical agents. Zentralbl. Hyg. Umweltmed., 202 (1): 41–50 (1999).
  • Resnick, L., K. Verron, S. Z. Salahuddin, S. Tondreau, and P. D. Markham: Stability and inactivation of HTLV-III/ LAY under clinical and laboratory environments. J. Am. Med. Assoc., 255: 1887–1981 (1986).
  • Reverdy, M. E., A. Martra, and J. Fleurette: Determination de l'activite bactericide de la Biseptine, associant chlorhexidine, chlorure de benzalkonium et alcool benzylique, sur 124 souches bacteriennes hospitali eres [Bactericidal activity determination of Biseptine, combination of chlorhexidine, benzalkonium chloride and benzylic alco-hol, on 124 hospital bacterial strains]. PathoL Biol. (Paris), 45 (4): 331–335 (1997).
  • Reverdy, M. E., M. Rougier, and J. Fleurette: Cinetique de bactericidie in vitro de la biseptine antiseptique associant trois principes actifs [Kinetics of in vitro bacteri-cidal activity of the antiseptic biseptine combining 3 active principles]. PathoL Biol. (Paris), 44 (7): 675–680 (1996).
  • Richards, R. M. and R. H. Cavill: Electron microscope study of the effect of benzal-konium, chlorhexidine and polymyxin on Pseadomonas cepacia. Microbios, 29 (115): 23–31 (1981).
  • Rietschel, R. L.: Physiologic response of chronically inflamed and accommodated hu-man skin. Curr. ProbL DermatoL, 23: 104–107 (1995).
  • Rikimaru, T., M. Kondo, S. Kondo, and K. Oizumi: Efficacy of common antiseptics against mycobacteria. Int. J. Tuberc. Lung Dis., 4 (6): 570–576 (2000).
  • Riolo, U., G. Finzi, I. Pandiani, and D. Ghermandi: Antibacterial activity of disinfec-tant solutions containing quaternary ammonium compounds for the storage of sur-gical instruments. Archivio per le Scienze Mediche, 139 (4): 491–497 (1982a).
  • Riolo, U., I. Pandiani, and G. Finzi: Behavior of disinfectant substances in compari-sons of bacterial strains. Archivio per le Scienze Mediche, 139 (4): 499–508 (1982b).
  • Romanowski, E. G., D. A. Barnhorst, R. P. Kowalski, and Y. J. Gordon: The survival of herpes simplex virus in multidose office ophthalmic solutions. Am. J. OphthalmoL, 128 (2): 239–240 (1999).
  • Ronnpagel, K., W. Liss, and W. Ahlf: Microbial bioassays to assess the toxicity of solid-associated contaminants. EcotoxicoL Environ. Saf, 31(2): 99–103 (1995). Roper, S. S. and H. E. Jones: An animal model for altering the iirtability threshold of normal skin. Contact Dermatitis, 13 (2): 91–97 (1985).
  • Rosskamp, E.: Air-conditioning plants—a health problem. Bundesgesundhblad, 3/90: 117–121 (1990).
  • Rot, A., M. Krieger, T. Brunner, S. C. Bischoff, T. J. Schall, and C. A. Dahinden: RANTES and macrophage inflammatory protein I alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med., 176 (6): 1489–1495 (1992).
  • Rudzki, E., T. Kecik, L. Portacha, P. Rebandel, and M. Pauk: Czestosc wystepowania uczulen na antybiotyki i srodki konserwujace w kroplach ocznych [Incidence of hy-persensitivity to antibiotics and preservatives in eye drops] Klin Oczna, 97 (3–4): 66–67 (1995).
  • Russell, J. A., R. K. Malcolm, K. Campbell, and A. D. Woolfson: High-performance liquid chromatographic determination of 17-beta-estradiol and 17-beta-estradiol-3-acetate solubilities and diffusion coefficients in silicone elastromeric intravaginal rings. J. Chromatogr. B. Biomed. Sci. AppL, 744 (1): 157–163 (2000).
  • Rustemeyer, T., B. Pilz, and P. J. Frosch: Contact allergies in medical occupations. Hautarzt, 45 (12): 834–844 (1994).
  • Rycroft, A. N. and C. McLay: Disinfectants in the control of small animal ringworm due to Microsporum canis. Veterinary Record, 129 (11): 239–241 (1991).
  • Saarinen-Savolainen, P., T. Jarvinen, K. Araki-Sasaki, H. Watanabe, and A. Urtti: Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm. Res., 15 (8): 1275–1280 (1998).
  • Sakagami, Y., H. Yamazaki, N. Ogasawara, H. Yokoyama, Y. Use, and T. Sato: The evaluation of genotoxic activities of disinfectants and their metabolites by umu test. MutaL Res., 209 (3–4): 155–160 (1988).
  • Sakagami, Y., H. Yokoyama, H. Nishimura, Y. Use, and T. Tashima: Mechanism of resistance to benzalkonium chloride by Pseudomonas aeruginosa. AppL Environ. MicrobioL, 55 (8): 2036–2040 (1989).
  • Saknimit, M., I. Inatsuki, Y. Sugiyarna, and K. Yaganmi: Virucidal efficacy of physico-chemical treatments against coronaviruses and parvoviruses of laboratory animals. Jikken Dobutsu. Exp. Animals, 37 (3): 341–345 (1988).
  • Sakuragi, T., K. Higa, K. Dan, and M. Okubo: Skin disinfectants for nerve blocks and their long-lasting antimicrobial effects. Masui Jpn. J. AnesthesioL, 39 (3): 328–334 (1990).
  • Sampath, L. A., N. Chowdhury, L. Caraos, and S. M. Modak: Infection resistance of surface modified catheters with either short-lived or prolonged activity. J. Hosp. In-fect., 30(3): 201–210 (1995).
  • Samples, J. R., P. S. Binder, and S. Nayak: The effect of epinephrine and benzal-konium chloride on cultured corneal endothelial and trabecular meshwork cells. Exp. Eye Res., 49 (1): 1–12 (1989).
  • Sanderson, C. J., D. G. Warren, and M. Strath: Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J. Exp. Med., 162: 60–74 (1985).
  • Santoni, G., A. Medica, P. Gratteri, S. Furlaneno, and S. Pinzauti: High-performance liquid chromatographic determination of benzalkonium and naphazoline or tetra-hydrozoline in nasal and ophthalmic solutions. Farmaco, 40(11): 751–754(1994).
  • Santos, G. C., S. Zucoloto, and S. B. Garcia: Endocrine cells in the denervated intes-tine. Int. J. Exp. PathoL, 81(4): 265–270 (2000).
  • Santoul, C., E. Decrouez, J. Y. Driot, and C. Bonne: Use of a specular microscope with pachymeter in ocular tolerance studies of eye drops in the rabbit. Evaluation of ocu-lar tolerance of benzalkonium chloride in aqueous solution O.01% and O.1%. Lens Eye Toxicity Res., 7 (3–4): 359–369 (1990).
  • Sasaki, H., C. Tei, K. Nishida, and J. Nakamura: Effect of ophthalmic preservatives on serum concentration and local irritation of ocularly applied insulin. Biol. PharmaceuL Bull., 18 (1): 169–171 (1995).
  • Sasaki, H., K. Yamamura, C. Tei, K. Nishida, and J. Nakamura: Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug. J. Drug Target, 3 (2): 129–135 (1995).
  • Sasaki, H., T. Nagano, K. Yamamura, K. Nishida, and J. Nakamura: Ophthalmic pre-servatives as absorption promoters for ocular drug delivery. J. Pharm. PharmacoL, 47 (9): 703–707 (1995).
  • Sasaki, H., C. Tei, K. Nishida, and J. Nakamura: Effect of ophthalmic preservatives on serum concentration and local irritation of ocularly applied insulin. Biol. Pharm. Bull., 18 (1): 169–171 (1995).
  • Sattar, S. A. and V. S. Springthorpe: Survival and disinfectant inactivation of the hu-man immunodeficiency virus. Rev. Infect. Dis., 13: 430–447 (1991).
  • Sautter, R. L., L. H. Mattman, and R. C. Legaspi: Serratiamarcescens meningitis asso-ciated with a contaminated benzalkonium chloride solution. Infect. Control, 5 (5): 223–225 (1984).
  • Scadding, G. K.: Adverse effects of benzalkonium chloride on the nasal mucosa: aller-gic rhinitis and rhinitis medicamentosa. Clin. Ther., 22 (7): 893–895 (2000).
  • Scheda, P., L. Zainpicinini, and L. Xerri: Determination in time of the residual antibac-terial activity after disinfection of hands with Citrosil products with benzalkonium chloride base. Minerva Chirurgica, 43 (21): 1845–1847 (1988).
  • Schep, L. J., D. S. Jones, and M. G. Shepherd: Primary interactions of three quaternary ammonium compounds with blastospores of Candida albi cans (MEN strain). Phann. Res., 12 (5): 649–652 (1995).
  • Schneider, T. A., II, C. M. Wittgen, C. H. Andrus, and D. L. Kaminski: Comparison of minimally invasive methods of parietal cell vagotomy in a porcine model. Surgery, 112(4): 649–654 (1992).
  • Schnuch, A., J. Geier, W. Uter, and P. J. Frosch: Patch testing with preservatives, antimicrobials and industrial biocides. Results from a multicentre study. Br. J. Dermatol., 138 (3): 467–476 (1998).
  • Schwarz, A., C. Krone, F. Trautinger, Y. Aragane, P. Neuner, T. A. Luger, and T. Schwarz: Pentoxifylline suppresses irritant and contact hypersensitivity reactions. J. Invest. Dermatol., 101 (4): 549–552 (1993).
  • Schwarz, A., S. Grabbe, H. Riemann, Y. Aragane, M. Simon, S. Manon, S. Andrade, T. A. Luger, A. Zlotnik, and T. Schwarz: In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol., 103 (2): 211–216 (1994).
  • Schweickart, V. L., C. J. Raport, R. Godiska, M. G. Byers, R. L. Eddy, Jr., T. B. Shows, and P. W. Gray: Cloning of human and mouse EBII, a lymphoid-specific G-pro-tein-coupled receptor encoded on human chromosome 17q12-q21.2. Genomics, 23 (3): 643–650 (1994).
  • Sebben, J. E.: Surgical antiseptics. J. Am. Acad. Dermatol., 9 (5): 759–765 (1983). See, N. A., C. Singaram, M. L. Epstein, J. L. Dahl, and P. Bass: Reinnervation of villi of rat jejunum following severe mucosal damage. Digest. Dis. Sci., 37 (3): 438–448 (1992).
  • Seebeck, J., D. Krebs, and A. Ziegler: Influence of salmeterol and benzalkonium chlo-ride on G-protein-mediated exocytotic responses of rat peritoneal mast cells. Eur. J. Pharmacol., 397 (1): 19–24 (2000).
  • Seebeck, J., M. L. Kruse, A. Schmidt-Choudhury, J. Schmidtmayer, and W. E. Schmidt: Pituitary adenylate cyclase activating polypeptide induces multiple sig-naling pathways in rat peritoneal mast cells. Eur. J. Pharmacol., 352 (2–3): 343–350 (1998).
  • Sehmi, R., A. J. Wardlaw, O. Cromwell, K. Kurihara, P. Waltmann, and A. B. Kay: Interleukin-5 selectively enhances the chemotactic response of eosinophils ob-tained from normal but not eosinophilic subjects. Blood, 79: 2952–2959 (1992).
  • Seppey, M., T. Schweri, and R. Hausler: Comparative randomised clinical study of tolerability and efficacy of Rhinomer Force 3 versus a reference product in post-op-erative care of the nasal fossae after endonasal surgery. ORL J. Otorhinolaryngol. Relat. Spec., 58 (2): 87–92 (1996).
  • Settembrini, L., R. Boylan, H. Strassler, and W. Scherer: A comparison of anti-microbial activity of etchants used for a total etch technique. Oper. Dent., 22 (2): 84–88 (1997).
  • Shaffer, M. P. and D. V. Belsito: Allergic contact dermatitis from gluteraldehyde in health-care workers. Contact Dermatitis, 43 (3): 150–156 (2000).
  • Shan, X., H. Luo, B. Houle, and J. Wu: Expression of a G-protein beta subunit-related gene during lymphocyte activation. InL ImmunoL, 6 (5): 739–749 (1994).
  • Shao, Z., Y. Li, R. Krishnamoorthy, T. Chermak, and A. K. Mitra: Differential effects of anionic, cationic, non-ionic, and physiologic surfactants on the dissociation, al-pha-chymotryptic degradation, and enteral absorption of insulin hexamers. Pharma-ceuL Res., 10 (2): 243–251 (1993).
  • Shephard, M. D. and M. J. Whiting: Nephelometric determination of total protein in cerebrospinal fluid and urine using benzalkonium chloirde as precipitation reagent. AnnaL Clin. Biochem., 29 (Pt 4): 411–417 (1992).
  • Sherwood Burge, P. and M. N. Richardson: Occupational asthma due to indirect expo-sure to lauryl dimethyl benzyl ammonium chloirde used in a floor cleaner. Thorax, 49: 842–843 (1994).
  • Sieling, P. A., D. Chatterjee, S. A. Porcelli, T. I. Prigozy, R. J. Mazzaccaro, T. Soriano, B. R. Bloom, M. B. Brenner, M. Kronenberg, P. J. Brennan, and R. L. Modlin: CD1-restricted T cell recognition of microbial lipoglycan antigens. Science, 269: 227–230 (1995).
  • Sikorski, E. E., G. F. Gerberick, C. A. Ryan, C. M. Miller, and G. M. Ridder: Phenotypic analysis of lymphocyte subpopulations in lymph nodes draining the ear following exposure to contact allergens and irritants. Fundam. AppL ToxicoL, 34 (1): 25–35 (1996).
  • Silvany, R. E., J. M. Dougherty, and J. P. McCulley: Effect of contact lens preserva-tives on Acanthamoeba. OphthalmoL, 98 (6): 854–857 (1991).
  • Singh, G. and J. Kaur: Iatrogenic dry eye: late effect of topical steroid formulations. J. Indian Med. Assoc., 90 (9): 235–237 (1992).
  • Singh, R. P., R. Patarca, J. Schwartz, P. Singh, and H. Cantor: Definition of a specific interaction between early-T-Iymphocyte-activation-1 (eta-1) protein and murine macrophages in vitro and in vivo. J. Exp. Med., 171: 1931–1942 (1990).
  • Smith, R. J., J. M. Justen, J. E. Bleasdale, and L. M. Sly: NPC 15669-modulated human polymorphonuclear neutrophil functional responsiveness: effects on receptor-cou-pled signal transduction. Br. J. PharmacoL, 114 (8): 1694–1702 (1995).
  • Sortino, G. and E. Rapisarda: Clinical statistical evaluation of the antiplaque efficacy of therapeutic aids. Minerva Stomatologica, 29 (3): 147–158 (1980).
  • Spicher, G. and J. Peters: Beeinflus sung der mikrobiziden Wirksamkeit von Formal-dehyd, Glutardialdehyd, Peressigsaure, Chloramin T (N-Chlor-4-toluolsulfon-saureamid), m-Kresol, Ethanol und Benzyldimethyldodecylammoniumbromid durch Blut (Modellversuche zur chemischen Instrumentendesinfektion) [Effect on the microbicidal efficacy of formaldehyde, gluteraldehyde, peracetic acid, chloramine T (N-chloro-4-toluenesulfonamide), m-cresol, ethanol and benzyldimethyldod-ecacylammonium bromide by blood (model experiments for chemical disinfection of instruments)]. ZentralbL Hyg. Umweltmed., 200 (5–6): 465–477 (1998).
  • Spire, B., F. Barre-Sinoussi, L. Montagnier, and J. C. Cherman: Inactivation of lymphadenopathy-associated virus by chemical disinfectants. Lancet, 2: 899–901 (1984).
  • Springthorpe, V. S. and S. A. Satter: Chemical disinfection of contaminated surfaces. CRC Grit. Revs. Environ. Control, 20: 169–229 (1990).
  • Stanford, D. and K. Georgouras: Allergic contact dermatitis from benzalkonium chlo-ride in plaster of Paris. Contact Dermatitis, 35 (6): 371–372 (1996).
  • Staniforth, P.: Allergy to benzalkonium chloride in plaster of Paris after sensitization to cetrimide. A case report. J. Bone ft. Surgery, 62-B (4): 500–501 (1980).
  • Stanley, P. J., W. M. Griffin, R. Wilson, M. A. Greenstone, I. S. Mackay, and P. J. Cole: Effect of betamethasone and betamethasone with neomycin nasal drops on human nasal mucociliary clearance and ciliary beat frequency. Thorax, 40 (8): 607–612 (1985).
  • Steinsvag, S. K., R. Bjerknes, and O. H. Berg: Effects of topical nasal steroids on hu-man respiratory mucosa and human granulocytes in vitro. Acta Otolaryngol., 116 (6): 868–875 (1996).
  • Stewart, S. J., G. R. Cunningham, and F. S. House: Activation of phospholipase D fol-lowing perturbation of the human T lymphocyte antigen receptor/CD3 complex is dependent upon protein kinase C. Cell. Signal., 5 (3): 315–323 (1993).
  • Stoler, M. H., T. A. Bonfiglio, R. T. Steigbigel, and M. Pereira: An atypical subcutane-ous infection associated with AIDS. Am. J. Clin. Pathol., 80: 714–718 (1983).
  • Storaas, T., M. Andersson, C. G. Persson, S. K. Steinsvag, G. Marko-Varga, and L. Greiff: Effects of benzalkonium chloride on innate immunity physiology of the hu-man nasal mucosa in vivo. Laryngoscope, 110 (9): 1543–1547 (2000).
  • Strader, C. D., T. M. Fong, M. R. Tota, D. Underwood, and R. A. F. Dixon: Structure and function of G protein-coupled receptors. Annu. Rev. Biochem., 63: 101–132 (1994).
  • Stryker, W. S., R. A. Gunn, and D. P. Francis: Outbreak of hepatitis B associated with acupuncture. J. Fam. Pract., 22 (2): 155–158 (1986).
  • SuIler, M. T. and A. D. Russell: Antibiotic and biocide resistance in methicillin-resis-tant Staphylococcus aureus and vancomycin-resistant enterococcus. J. Hosp. In-fect., 43 (4): 281–291 (1999).
  • Sullivan, L. J., F. McCurrach, S. Lee, H. R. Taylor, M. Rolando, C. Marechal-Courtois, C. Creuzot-Garcher, D. L. Easty, C. Karabatsas, M. Bingh Hoh, C. Faschinger, and L. Laroche: Efficacy and safety of O.3% carbomer gel compared to placebo in pa-tients with moderate-to-severe dry eye syndrome. Ophthalmology, 104(9): 1402–1408 (1997).
  • Suzuki, J., H. Komatsuzawa, K. Kozai, and N. Nagasaka: In vitro susceptibility of Staphylococcus aureus including MRSA to four disinfectants. ASDC J. Dent. Child, 64 (4): 260–263 (1997).
  • Suzuki, S., Y. Nakamura, M. Kaneko, K. Mori, and Y. Watanabe: Analysis of benzalkonium chloride by gas chromatography. J. Chromatogr., 463 (1): 188–191 (1989).
  • Tai, P. C., L. Sun, and C. J. F. Spry: Effects of IL-5, granulocyte/macrophage col-ony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin. Exp. Immunol., 85: 312–316 (1991).
  • Takahashi, N.: Quantitative cytotoxicity of preservatives evaluated in cell culture with Chang' s human conjunctival cells—effect of temperature on cytotoxicity. Jpn. J. Ophthalmol., 26 (2): 234–238 (1982).
  • Takahashi, N.: A new method evaluating quantitative time-dependent cytotoxicity of ophthalmic solutions in cell culture. Beta-adrenergic blocking agents. Graefes Ar-chive for ClM. Exp. Ophthalmol., 220 (6): 264–267 (1983).
  • Takahashi, N., K. Fujikawa, M. Miyakoshi, K. Teraoka, and K. Taniuchi: A flow cytometric study of the effects of benzalkonium chloride on the cell cycle. Nippon Ganka Gakkai Zasshi—Acta Societatis Ophthalmologicae Japonicae, 96(7): 823–827 (1992).
  • Takeo, Y., S. Oie, A. Kayima, N. Konishi, and T. Nakazawa: Efficacy of disinfectants against biofilm cells of Pseudomonas aeruginosa. Microbios, 78 (318): 19–26 (1994).
  • Takeuchi, N., Y. Takikawa, and N. Shibuya: Actions of benzalkonium chloride as a po-tent depressant at the neuromuscular junction. Neuropharmacology, 32 (4): 377–385 (1993).
  • Tanaka, K., K. Kumon, T. Ifirata, F. Yamamoto, and T. Fujita: Evaluation of rapid dry-ing hand disinfectant preparations in the intensive care unit. Grit. Care Med., 16(5): 540–542 (1988).
  • Tarbox, B. B., B. P. Conroy, E. S. Malicky, F. W. Moussa, D. E. Hockman, J. O. Anglen, W. A. Simpson, E. H. Adelstein, G. Christensen, and B. J. Gainor: Benzalkonium chloride. A potential disinfecting irrigation solution for orthopaedic wounds. ClM. Orthop., 346: 255–261 (1998).
  • Tartaglia, L. A. and D. V. Goeddel: Two TNF receptors. Immunol. Today, 13: 151–153 (1992).
  • Taylor, R. B., S. Toasaksiri, and R. G. Reid: Capillary electrophoresis and liquid chro-matography in the analysis of some quaternary ammonium salts used in lozenges as antibacterial agents. J. Capillary Electrophor., 5 (1–2): 45–50 (1998).
  • Taylor, R. B., S. Toasaksiri, and R. G. Reid: Determination of antibacterial quaternary ammonium compounds in lozenges by capillary electrophoresis. J. Chromatogr. A., 798 (1–2): 335–343 (1998).
  • Taylor, R. B., S. Toasaksiri, R. G. Reid, and D. Wood: Determination of the quaternary ammonium compounds dequalinium and cetylpyridinium chlorides in candy-based lozenges by high-performance liquid chromatography. Analyst, 122 (9): 973–976 (1997).
  • Tebbs, S. E. and T. S. Elliott: A novel antimicrobial central venous catheter impreg-nated with benzalkonium chloride. J. Antimicrob. Chemother., 31(2): 261–271 (1993).
  • Tebbs, S. E. and T. S. Elliott: Modification of central venous catheter polymers to pre-vent in vitro microbial colonisation. Eur. J. Clin. Microbiol. Infect. Dis., 13 (2): 111–117 (1994).
  • Telford, E. A., M. S. Watson, H. C. Aird, J. Perry, and A. J. Davison: The DNA se-quence of equine herpesvirus 2. J. Mol. Biol., 249 (3): 520–528 (1995).
  • Tevi-Benissan, C., M. Makuva, A. Morelli, M. C. Georges-Courbot, M. Matta, A. Georges, and L. Belec: Protection of cynomolgus macaque against cervicovaginal transmission of SIVmac251 by the spermicide benzalkonium chloride. J. Acquir. Immune Defic. Syndr., 24 (2): 147–153 (2000).
  • Thelen, M., M. Uguccioni, and J. Bosiger: PI 3-kinase-dependent and independent chemotaxis of human neutrophil leukocytes. Biochem. Biophys. Res. Commun., 217 (3): 1255–1262 (1995).
  • Thompson, K. D.: Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus. Antiviral Res., 39 (1): 55–61 (1998).
  • Trevisan, G., F. Kokelj, and E. Briscik: Contact dermatitis caused by benzalkonium chloride mimicking metal dermatitis. Giornale Italian° di Dermatologia e Venere-ologia, 123 (10): 513–515 (1988).
  • Tripathi, B. J. and R. C. Tripathi: Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro. Lens Eye Toxicity Res., 6 (3): 395–403 (1989).
  • Tripathi, B. J., R. C. Tripathi, and S. P. Kolli: Cytotoxicity of ophthalmic preservatives on human corneal epithelium. Lens Eye Toxicity Res., 9 (3–4): 361–375 (1992).Tsai, C. J., L. R. Hsu, J. Y. Fang, and H. H. Lin: Chitosan hydrogel as a base for trans- dermal delivery of berberine and its evaluation in rat skin. Biol. Pharm. Bull., 22 (4): 397–401 (1999).
  • Turacli, E., K. Budak, A. Kaur, B. Mizrak, and C. Ekinci: The effects of long-term top-ical glaucoma medication on conjunctival impression cytology. Int. OphthalmoL, 21(1): 27–33 (1997).
  • UbeIs, J. L., M. D. Cartney, W. K. Lantz, J. Beaird, A. Dayalan, and H. F. Edelhauser: Effects of preservative-free artificial tear solutions on corneal epithelial structure and function. Arch. OphthalmoL, 113 (3): 371–378 (1995).
  • UbeIs, J. L., E. M. Woo, W. J. Watts, L. K. Smith, U. Zylstra, J. Beaird, and M. D. McCartney: Conjunctival permeability and ultrastructure. Effects of benzalkonium chloride and artificial tears. Adv. Exp. Med. Biol., 438: 723–730 (1998).
  • UbeIs, J. L., M. D. McCartney, W. K. Lantz, J. Beaird, A. Dayalan, and H. F. Edelhauser: Effects of preservative-free artificial tear solutions on corneal epithe-lial structure and function. Arch. OphthalmoL, 113 (3): 371–378 (1995).
  • Uwagawa, T., N. Okabe, T. Matsumoto, H. Kurihara, S. Miyamoto, Y. Tujihara, T. Takahashi, I. Sakurai, F. Matsumoto, and Y. Yamazaki: [Preventive effect of postoperative disinfection of endoscope on bacterial adhesion to endoscope] Kansenshogaku Zasshi, 73 (10): 1019–1024 (1999).
  • Valot, S., D. Edert, and A. Le Faou: A simple method for the in vitro study of the virucidal activity of disinfectants. J. ViroL Methods, 86 (1): 21–24 (2000). Van Berkel, M. and de Wolff, F. A.: Survival after acute benzalkonium chloride poi- soning. Hum. ToxicoL, 7 (2): 191–193 (1988).
  • van de Sandt, J. J., W. J. Maas, P. C. Doornink, and A. A. Rutten: Release of arachidonic and linoleic acid metabolites in skin organ cultures as characteristics of in vitro skin irritancy. Fundam. AppL ToxicoL, 25 (1): 20–28 (1995).
  • Van de Donk, H. J., I. P. Muller-Plantema, J. Zuidema, and F. W. Merkus: The effects of preservatives on the ciliary beat frequency of chicken embryo tracheas. Rhinology, 18 (3): 119–133 (1980).
  • Van de Donk, H. J., A. G. van den Heuvel, J. Zuidema, and F. W. Merkus: The effects of nasal drops and their additives on human nasal mucociliary clearance. Rhinology, 20 (3): 127–137 (1982a).
  • Van de Donk, H. J., J. Zuidema, and F. W. Merkus: Correlation between the sensitivity of the ciliary beat frequency of human adenoid tissue and chicken embryo tracheas for some drugs. Rhinology, 20 (2): 81–87 (1982b).
  • Van de Voorde, H., P. van Dijck, and G. Reybrouck: Influence of the growth character-istics of Candida albicans on disinfectant testing. Zentralblau fur Bakteriologie, Mikrobiologie und Hygiene—Serie B, Umwelthygiene, Krankenhaushygiene, Arbeit-shygiene, Praventive Medizin, 184 (2): 160–166 (1987).
  • Van der Valk, P. G., J. P. Nater, and E. Bleumink: The influence of low concentrations of irritants on skin barrier function as determined by water vapour loss. OccupaL Environ. Dermatoses, 33 (3): 89–91 (1985).
  • Van Deventer, S. J. H., M. Hart, T. Van der Poll, C. E. Hack, and L. A. Aarden: Endotoxin and tumor necrosis factor-a-induced interieukin-8 release in humans. J. Infect. Dis., 167: 461–464 (1993).
  • Vassiliadis, S. and J. Papamatheakis: The p2tras protein as an intermediate signaling molecule in the IL-4-induced HLA-DR expression on normal and leukemic human myeloid cells. Cell. Immunol., 142 (2): 426–433 (1992).
  • Vaughan, J. S. and D. A. Porter: A new in vitro method for assessing the potential tox-icity of sort contact lens care solutions. CLAO J., 19 (1): 54–57 (1993).
  • Velandia, M., S. K. Fridkin, V. Cardenas, J. Boshell, G. Ramirez, L. Bland, A. Iglesias, and W. Jarvis: Transmission of IRV in dialysis centre. Lancet, 345 (8962): 1417–1422 (1995).
  • Vidal, M., F. Lefevre, B. Rouot, J. Sainte-Marie, and J. Philippot: A GTP-binding pro-tein modulates a Ca2+ pump present in reticulocyte endocytic vesicles. Biochem. MoL Biol. InL, 35 (4): 889–898 (1995).
  • Velandia, M., S. K. Fridkin, V. Cardenas, J. Boshell, G. Ramirez, L. Bland, A. Iglesias, and W. Jarvis: Transmission of HIV in dialysis centre. Lancet, 345 (8962): 1417–1422 (1995).
  • Vidal, M., F. Lefevre, B. Rouot, J. Sainte-Marie, and J. Philippot: A GTP-binding pro-tein modulates a Ca2+ pump present in reticulocyte endocytic vesicles. Biochem. MoL Biol. InL, 35 (4):889–898 (1995).
  • Vitale, N., H. Mukai, B. Rouot, D. Thierse, D. Aunis, and M. F. Bader: Exocytosis in chromaffin cells. Possible involvement of the heterotrimeric GTP-binding protein G(o). J. Biol. Chem., 268 (20): 14715–14723 (1993).
  • Vyakarnam, A., J. McKeating, A. Meager, and P. C. Beverly: Tumour necrosis factors induced by HIV-I in peripheral blood mononuclear cells potentiate virus replica-tion. AIDS, 4: 21–28 (1990).
  • Waclawski, E. R., L. G. McAlpine, and N. C. Thompson: Occupational asthma in nurses due to chlorhexidine and alcohol aerosols. Br. Med. J.,298: 929–930 (1989).
  • Wadhams, P. S., J. Griffith, P. Nikravesh, and D. Chodosh: Efficacy of a surfactant, allantoin, and benzalkonium chloride solution for onychomycosis. Preliminary re-sults of treatment with periodic debridement. J. Am. Podiatr. Med. Assoc., 89 (3): 124–130 (1999).
  • Wahlberg, J. E. and H. I. Maibach: Sterile cutaneous pustules: a manifestation of pri-mary irritancy? Identification of contact pustulogens. J. Invest. Dermato1, 76 (5): 381–383 (1981).
  • Wahlberg, J. E., K. Wrangsjo, and A. Metasalo: Skin irritancy from nonanoic acid. Contact Dermatitis, 13 (4): 266–269 (1985).
  • Wahlberg, J. E.: Measurement of skin-fold thickness in the guinea pig. Assessment of edema-inducing capacity of cutting fluids, acids, alkalis, formalin and dimethyl sulfoxide. Contact Dermatitis, 28 (3): 141–145 (1993).
  • Wainberg, M. A., B. Spira, G. Bleau, and R. Thomas: Inactivation of human immuno-deficiency virus type I in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride. J. Clin. MicrobioL, 28 (1): 156–158 (1990).
  • Wallengren, J.: Dual effects of CGRP-antagonist on allergic contact dermatitis in hu-man skin. Contact Dermatitis, 43 (3): 137–143 (2000).
  • Wang, H. Z., S. J. Hong, and K. Y. Wu: Change of calcium and cANfP concentration by adrenoceptor agents in cultured porcine corneal endothelial cells. J. OcuL PharmacoL Ther., 16 (4): 299–309 (2000).
  • Warringa, R. A. J., H. J. J. Mengelers, P. H. M. Kuijper, J. A. M. Raaijmakers, P. L. B. Bruijnzeet, and L. Koenderman: In vivo priming of platelet-activating factor-in-duced eosinophil chemotaxis in allergic asthmatic individuals. Blood, 79: 1836–1841 (1992).
  • Watanabe, Y., H. Miyata, and H. Sato: Inactivation of laboratory animal RNA viruses by physicochemical treatment. Jikken Dobutsu. Exp. Animals, 38 (4): 305–311 (1989).
  • Watanabe, Y., H. Nawa, and N. Koike: [Effects of antiseptics against methicillin-resistant Staphylococcus aureus] Kansenshogaku Zasshi, 69 (11): 1235–1243 (1995). Weiler, E. D., M. A. Jayjock, and D. E. Greenley: Quality requirements for biocides in the 1990s. QuaL Assur., 2 (3): 244–250 (1993).
  • Weir, S. C., H. Lee, and J. T. Trevors: Survival and respiratory activity of genetically engineered Pseudomonas spp. exposed to antimicrobial agents in broth and soil. Microb. Rel., 2 (4): 239–245 (1994).
  • Wenzel, H. R., A. Feldmann, S. Engelbrecht, and H. Tschesche: Activation of the hu-man leukocyte proteinases elastase and cathepsin G by various surfactants. Biol. Chem. Hoppe-Seyler, 371 (8): 721–724 (1990).
  • Wernert, N., M. B. Raes, P. Lasalle, M. P. Dehouck, B. Gosselin, B. Vandenbunder, and D. Stehelin: c-ets I proto-oncogene is a transcription factor expressed in endo-thelial cells during tumor vascularization and other forms of angiogenesis in hu-mans. Am. J. PathoL, 140 (1). 119–127 (1992).
  • Weston, A. and E. S. Assem: Possible link between anaphylactoid reactions to anaes-thetics and chemicals in cosmetics and biocides. Agents Actions, 41: C138-C139 (1994).
  • Wilhem, K. P., G. Freitag, and H. H. Wolff. Surfactant-induced skin irritation and skin repair: evaluation of a cumulative human irritation model by noninvasive tech-niques. J. Am. Acad. DermatoL, 31(6): 981–987 (1994).
  • Willemot, J.: Le monohydrate du bromure de benzododecinium [Benzododecinium bromide monohydrate]. Ann. Pharm. Fr., 53 (2): 83–85 (1995).
  • Williams, D. E., K. D. Nguyen, S. Shapourifar-Tehrani, S. Kitada, and D. A. Lee: Ef-fects of timolol, betaxolol, and levobunolol on human Tenon's fibroblasts in tissue culture. Invest. Ophthalmol. Visual Sci., 33 (7): 2233–2241 (1992).
  • Willis, C. M., E. Young, D. R. Brandon, and J. D. Wilkinson: Immunopathological and ultrastructural findings in human allergic and irritant contact dermatitis. Br. J. DermatoL, 115 (3): 305–316 (1986).
  • Willis, C. M., J. M. Stephens, and J. D. Wilkinson: Experimentally-induced irritant contact dermatitis. Determination of optimum irritant concentrations. Contact Der-matitis, 18 (1): 20–24 (1988).
  • Willis, C. M., C. J. Stephens, and J. D. Wilkinson: Differential effects of structurally unrelated chemical irritants on the density and morphology of epidermal CD1+ cells. J. Invest. DermatoL, 95 (6): 711–716 (1990).
  • Willis, C. M., C. J. Stephens, and J. D. Wilkinson: Differential effects of structurally unrelated chemical irritants on the density of proliferating keratinocytes in 48 h patch test reactions. J. Invest. DermatoL, 99 (4): 449–453 (1992).
  • Willis, C. M., C. J. Stephens, and J. D. Wilkinson: Differential patterns of epidermal leukocyte infiltration in patch test reactions to structurally unrelated chemical initants. J. Invest. DermatoL, 101 (3): 364–370 (1993).
  • Wilmer, J. L., F. G. Burleson, F. Kayama, J. Kanno, and M. I. Luster: Cytokine induc-tion in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J. Invest. DermatoL, 102 (6): 915–922 (1994).
  • Withrow, T. J., N. T. Brown, V. M. Hitchins, and A. G. Strickland: Cytotoxicity and mutagenicity of ophthalmic solution preservatives and UVA radiation in L5178Y cells. Photochem. PhotobioL, 50 (3): 385–389 (1989).
  • Wolkenstein, P. and L. Vaillant: Les antiseptiques en peau lesee [Antiseptics in skin diseases] Ann. DermatoL VenereoL, 123 (5): 343–348 (1996).
  • Wood, A., and D. Payne: The action of three antiseptics/disinfectants against envel-oped and non-enveloped viruses. J. Hosp. Infect., 38 (4): 283–295 (1998).
  • Woolfson, A. D., G. R. Elliott, C. A. Gilligan, and C. M. Passmore: Design of an intravaginal ring for the controlled delivery of 17-beta-estradiol as its 3-acetate es-ter. J. Controlled Release, 61(3): 319–328 (1999).
  • Wu, D., G. J. LaRosa, and M. I. Simon: G protein-coupled signal transduction path-ways for interleukin-8. Science, 261 (5117): 101–103 (1993).
  • Wu, P. C., J. Y. Fang, Y. B. Huang, and Y. H. Tsai: In vitro effect of penetration enhancers on sodium nonivamide acetate in rat skin. Biol. Pharm. Bull., 18 (12): 1790–1792 (1995).
  • Yalvac, I. S., G. Gedikoglu, Y. Karagoz, U. Akgun, A. Nurozler, F. Koc, R. Kasim, and S. Duman: Effects of antiglaucoma drugs on ocular surface. Acta OphthalmoL Scand., 73 (3): 246–248 (1995).
  • Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu: Purified interleukin 5 supports the terminal differentiation and prolifer-ation of murine eosinophilic precursors. J. Exp. Med., 167: 43–56 (1988).
  • Yang, H. J., T. Sato, M. Matsubara, and T. Tanishima: Endothelial wound-healing in penetrating corneal graft for experimental bullous keratopathy in rabbit. Jpn. J. OphthalmoL, 29 (4): 378–393 (1985).
  • Yasuda, T., S. Yoshimura, Y. Katsuno, H. Takada, M. Ito, M. Takahashi, F. Yahazaki, J. Iriyama, S. Ishigo, and Y. Asano: Comparison of bactericidal activities of various disinfectants against methicillin-sensitive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus. Postgrad. Med. J., 69 (Suppl. 3): S66-S69 (1993).
  • Yasuda, T., Y. Yoshimura, H. Takada, S. Kawaguchi, M. Ito, F. Yamazaki, J. Iriyama, S. Ishigo, and Y. Asano: Comparison of bactericidal effects of commonly used anti-septics against pathogens causing nosocomial infections. Part 2. Dermatology, 195 Suppl 2: 19–28 (1997).
  • Yazdani, A., T. Takahashi, D. Bagnol, S. J. Watson, and C. Owyang: Functional signif-icance of a newly discovered neuropeptide, orphanin FQ, in rat gastrointestinal mo-tility. Gastroenterology, 116 (1): 108–117 (1999).
  • Ye, W. P. and Y. W. Chien: Dual-controlled drug delivery across biodegradable co-polymer. I. Delivery kinetics of levonorgestrel and estradiol through (caprolactone/ lactide) block copolymer. Pharm. Dev. TechnoL, 1 (1): 1–9 (1996).
  • Zaidi, M., M. Angulo, and J. Sifuentes-Osomio: Disinfection and sterilization prac-tices in Mexico. J. Hosp. Infect., 31(1): 25–32 (1995).
  • Zanetti, S., P. L. Fiori, A. Pinna, S. Usai, F. Carta, and G. Fadda: Susceptibility of Acanthamoeba castellanii to contact lens disinfecting solutions. Antimicrob Agents Chemother 39 (7): 1596–1598 (1995).
  • Zawadzka, E., P. Stefanski, and M. M. Zgoda: Some physico-chemical properties mi-celle—benzalkonium chloride (BAC) adduct on interface in selected eye drops. Acta Pol. Pharm., 52 (4): 275–279 (1995).
  • Zhang, Y. G., W. J. Wright, W. K. Tam, T. H. Nguyen-Dang, C. M. Salome, and A. J. Woolcock: Effect of inhaled preservatives on asthmatic subjects. H. Benzalkonium chloride. Am. Rev. Respir. Dis., 141: 1405–1408 (1990).
  • Zorko, M., M. Pooga, K. Saar, K. Rezaei, and U. Langel: Differential regulation of GTPase activity by mastoparan and galparan. Arch. Biochem. Biophys., 349 (2): 321–328 (1998).
  • Zucoloto, S., J. C. Silva, J. S. Oliveira, and G. Muccillo: The chronological relation-ship between the thickening of smooth muscle, epithelial cell proliferation and myenteric neural denervation in the rat jejunum. Cell Prolifer., 24(1): 15–20 (1991).
  • Zucoloto, S., D. A. de Deus, A. A. Martins, V. F. Muglia, J. K. Kajiwara, and S. B. Gar-cia: The relationship between myenteric neuronal denervation, smooth muscle thickening and epithelial cell proliferation in the rat colon. Res. Exp. Med. (Berl), 197 (2): 117–124 (1997).
  • Zufferey, M. M.: Real and false risks of local contraception: spermicides and the dia-phragm. J. de Gynecologie, Obstetrique et Biologie de la Reproduction, 14 (3): 359–363 (1985).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.